2f:I[703058,["/_next/static/immutable/chunks/3bhq_5eh1d760.js","/_next/static/immutable/chunks/1855-ogyi8eh4.js","/_next/static/immutable/chunks/2pfsjpn6k6zlg.js","/_next/static/immutable/chunks/26c7v3_3uwnwu.js","/_next/static/immutable/chunks/25a3ozcrvi1ff.js","/_next/static/immutable/chunks/2r4wx50nvjh_4.js","/_next/static/immutable/chunks/23fsw06hsi5b1.js","/_next/static/immutable/chunks/06_yt270h41rg.js","/_next/static/immutable/chunks/3ezsiz-7shkna.js","/_next/static/immutable/chunks/20x2y96ldu5wx.js","/_next/static/immutable/chunks/2lxntcm3pd1_h.js","/_next/static/immutable/chunks/00dgco8irq3jw.js","/_next/static/immutable/chunks/00nwe-kq0rboc.js","/_next/static/immutable/chunks/2051ffx3xzio9.js"],"PaperListPageClient"] 30:T899,Understanding which children present with skin disease and reach specialty care is essential for characterizing patterns of disease frequency and care use. To describe the frequencies of common pediatric skin diseases and patterns of dermatology use, stratified by race and ethnicity, across 8 US children's hospitals participating in the PEDSnet system. This was a multicenter cross-sectional study of 8 US children's hospitals in PEDSnet from January 2009 to July 2022. Data were analyzed from January 3 to March 26, 2024. The study cohort included children with 1 or more dermatology clinic visit or 2 or more non-dermatology clinic visits coded for atopic dermatitis (AD), acne, infantile hemangioma, psoriasis, or hidradenitis suppurativa (HS). Disease frequency per 100 000 children and proportion of children using dermatology care for each condition, stratified by race and ethnicity. Of 536 776 patients, the mean (SD) age was 6.4 (6.3) years, 51.5% were female, and 0.2% were American Indian or Alaska Native, 6.4% Asian, 27.9% Black, 14.1% Hispanic, 0.3% Native Hawaiian or Other Pacific Islander, 8.4% non-Hispanic, 44.3% White, 4.3% multiple races, 5.5% unknown ethnicity, and 16.6% unknown race. Case counts were 377 970 for AD, 139 632 for acne, 54 305 for infantile hemangioma, 11 339 for psoriasis, and 5722 for HS. Electronic health record-derived frequencies varied across race and ethnicity groups. There were 10 469 (95% CI, 10 414-10 524) cases of AD per 100 000 Black children compared with 3099 (95% CI, 3083-3114) per 100 000 White children. There were 290 (95% CI, 280-300) cases of infantile hemangioma per 100 000 Black children compared with 764 (95% CI, 756-772) per 100 000 White children. Black children had a low proportion of dermatology use across all 5 conditions, yet high frequencies of AD, acne, and HS. In this study, across all studied conditions, Black children had a low proportion of dermatology use at participating PEDSnet US children's hospitals, despite having high frequencies of AD, acne, and HS. Further research is required to determine whether these patterns represent appropriate specialty care use or reflect gaps in care.31:Tccc, Importance Understanding which children present with skin disease and reach specialty care is essential for characterizing patterns of disease frequency and care use. Objective To describe the frequencies of common pediatric skin diseases and patterns of dermatology use, stratified by race and ethnicity, across 8 US children’s hospitals participating in the PEDSnet system. Design, Setting, and Participants This was a multicenter cross-sectional study of 8 US children’s hospitals in PEDSnet from January 2009 to July 2022. Data were analyzed from January 3 to March 26, 2024. The study cohort included children with 1 or more dermatology clinic visit or 2 or more non–dermatology clinic visits coded for atopic dermatitis (AD), acne, infantile hemangioma, psoriasis, or hidradenitis suppurativa (HS). Main Outcomes and Measures Disease frequency per 100 000 children and proportion of children using dermatology care for each condition, stratified by race and ethnicity. Results Of 536 776 patients, the mean (SD) age was 6.4 (6.3) years, 51.5% were female, and 0.2% were American Indian or Alaska Native, 6.4% Asian, 27.9% Black, 14.1% Hispanic, 0.3% Native Hawaiian or Other Pacific Islander, 8.4% non-Hispanic, 44.3% White, 4.3% multiple races, 5.5% unknown ethnicity, and 16.6% unknown race. Case counts were 377 970 for AD, 139 632 for acne, 54 305 for infantile hemangioma, 11 339 for psoriasis, and 5722 for HS. Electronic health record–derived frequencies varied across race and ethnicity groups. There were 10 469 (95% CI, 10 414-10 524) cases of AD per 100 000 Black children compared with 3099 (95% CI, 3083-3114) per 100 000 White children. There were 290 (95% CI, 280-300) cases of infantile hemangioma per 100 000 Black children compared with 764 (95% CI, 756-772) per 100 000 White children. Black children had a low proportion of dermatology use across all 5 conditions, yet high frequencies of AD, acne, and HS. Conclusions and Relevance In this study, across all studied conditions, Black children had a low proportion of dermatology use at participating PEDSnet US children’s hospitals, despite having high frequencies of AD, acne, and HS. Further research is required to determine whether these patterns represent appropriate specialty care use or reflect gaps in care. 32:T53e,Of 549 included participants with chronic skin diseases, 287 (52.3%) were female, 262 (47.7%) were male, and the median (IQR) age was 36 (30-45) years. A total of 249 patients (45.1%) had atopic dermatitis, 246 (44.8%) had acne, and 113 (20.6%) had psoriasis. The anxiety, depression, social satisfaction, and social isolation short-form measures demonstrated adequate structural validity (ie, all with comparative fit index and/or Tucker-Lewis index values greater than 0.95; standardized root mean residual values less than 0.08) and internal consistency (Cronbach α values greater than 0.90). All measures showed sufficient construct validity on known-groups and convergent validity testing (eg, magnitude of Pearson correlations between measures evaluating similar underlying constructs with values of 0.30 or greater). When comparing responsiveness based on standardized response means (SRMs), the pain (SRM, 0.41) and itch intensity (SRM range, 0.32-0.44) measures showed similar responsiveness as the Skindex-29 symptoms domain (SRM, 0.47), and the social satisfaction (SRM, -0.20) and isolation (SRM, 0.27) measures showed similar responsiveness to the Skindex-29 functioning domain (SRM, 0.25). Responsiveness of the anxiety (SRM, 0.11) and depression (SRM, 0.16) measures were lower than the Skindex-29 emotions domain (SRM, 0.43).33:Tb6c,Patient-Reported Outcomes Measurement Information System (PROMIS) is a generalized set of patient-reported outcome measures (PROMs) that can be readily integrated into the dermatologic clinic setting, but the measurement properties of these PROMs among patients with a range of chronic skin diseases have yet to be established. To evaluate the structural validity, internal consistency, construct validity, and responsiveness of PROMIS short-form measures for anxiety, depression, social satisfaction, and social isolation as well as the construct validity and responsiveness of single-item pain and itch intensity measures. In this cohort study, adults 18 years and older with a self-reported chronic skin disease (eg, atopic dermatitis, acne, psoriasis) were recruited in February 2025 from across the US via an online survey platform. Enrolled participants completed a baseline survey of PROMIS and several other relevant measures and then a follow-up survey 3 months later. Measures collected include the PROMIS measures, Dermatology Life Quality Index, Skindex-29, a baseline patient global assessment, and a change in skin disease anchor question at follow-up. Structural validity, internal consistency, construct validity, and responsiveness were evaluated for the short-form measures. Construct validity and responsiveness were assessed for the single-item measures. Of 549 included participants with chronic skin diseases, 287 (52.3%) were female, 262 (47.7%) were male, and the median (IQR) age was 36 (30-45) years. A total of 249 patients (45.1%) had atopic dermatitis, 246 (44.8%) had acne, and 113 (20.6%) had psoriasis. The anxiety, depression, social satisfaction, and social isolation short-form measures demonstrated adequate structural validity (ie, all with comparative fit index and/or Tucker-Lewis index values greater than 0.95; standardized root mean residual values less than 0.08) and internal consistency (Cronbach α values greater than 0.90). All measures showed sufficient construct validity on known-groups and convergent validity testing (eg, magnitude of Pearson correlations between measures evaluating similar underlying constructs with values of 0.30 or greater). When comparing responsiveness based on standardized response means (SRMs), the pain (SRM, 0.41) and itch intensity (SRM range, 0.32-0.44) measures showed similar responsiveness as the Skindex-29 symptoms domain (SRM, 0.47), and the social satisfaction (SRM, -0.20) and isolation (SRM, 0.27) measures showed similar responsiveness to the Skindex-29 functioning domain (SRM, 0.25). Responsiveness of the anxiety (SRM, 0.11) and depression (SRM, 0.16) measures were lower than the Skindex-29 emotions domain (SRM, 0.43). In this study, PROMIS measures were valid for assessing the physical, emotional, and social effects of chronic skin diseases, and measures for physical and social impact tracked improvements with treatment.34:Tf96, Importance Patient-Reported Outcomes Measurement Information System (PROMIS) is a generalized set of patient-reported outcome measures (PROMs) that can be readily integrated into the dermatologic clinic setting, but the measurement properties of these PROMs among patients with a range of chronic skin diseases have yet to be established. Objective To evaluate the structural validity, internal consistency, construct validity, and responsiveness of PROMIS short-form measures for anxiety, depression, social satisfaction, and social isolation as well as the construct validity and responsiveness of single-item pain and itch intensity measures. Design, Setting, and Participants In this cohort study, adults 18 years and older with a self-reported chronic skin disease (eg, atopic dermatitis, acne, psoriasis) were recruited in February 2025 from across the US via an online survey platform. Enrolled participants completed a baseline survey of PROMIS and several other relevant measures and then a follow-up survey 3 months later. Main Outcomes and Measures Measures collected include the PROMIS measures, Dermatology Life Quality Index, Skindex-29, a baseline patient global assessment, and a change in skin disease anchor question at follow-up. Structural validity, internal consistency, construct validity, and responsiveness were evaluated for the short-form measures. Construct validity and responsiveness were assessed for the single-item measures. Results Of 549 included participants with chronic skin diseases, 287 (52.3%) were female, 262 (47.7%) were male, and the median (IQR) age was 36 (30-45) years. A total of 249 patients (45.1%) had atopic dermatitis, 246 (44.8%) had acne, and 113 (20.6%) had psoriasis. The anxiety, depression, social satisfaction, and social isolation short-form measures demonstrated adequate structural validity (ie, all with comparative fit index and/or Tucker-Lewis index values greater than 0.95; standardized root mean residual values less than 0.08) and internal consistency (Cronbach α values greater than 0.90). All measures showed sufficient construct validity on known-groups and convergent validity testing (eg, magnitude of Pearson correlations between measures evaluating similar underlying constructs with values of 0.30 or greater). When comparing responsiveness based on standardized response means (SRMs), the pain (SRM, 0.41) and itch intensity (SRM range, 0.32-0.44) measures showed similar responsiveness as the Skindex-29 symptoms domain (SRM, 0.47), and the social satisfaction (SRM, −0.20) and isolation (SRM, 0.27) measures showed similar responsiveness to the Skindex-29 functioning domain (SRM, 0.25). Responsiveness of the anxiety (SRM, 0.11) and depression (SRM, 0.16) measures were lower than the Skindex-29 emotions domain (SRM, 0.43). Conclusions and Relevance In this study, PROMIS measures were valid for assessing the physical, emotional, and social effects of chronic skin diseases, and measures for physical and social impact tracked improvements with treatment. 35:T79c,Patients with skin of color (SOC) face unique dermatologic challenges that are often underrepresented in research and in dermatological education, creating critical gaps in care. We aimed to identify and explore key gaps in research and clinical management for SOC across four domains: skin diseases, hair disorders, photoprotection, and aesthetic procedures. An international panel reviewed articles retrieved from PubMed using the search terms "skin of color" or "skin of colour" in titles and abstracts from September 2019 to September 2024. Inflammatory skin diseases, including acne, atopic dermatitis, psoriasis, and rosacea, are common in SOC subjects, necessitating tailored diagnostic and therapeutic approaches due to unique clinical presentations and specific challenges such as post-inflammatory hyperpigmentation and erythema detection. Pigmentary disorders such as melasma and acne-induced hyperpigmentation significantly impact quality of life in SOC, requiring cautious treatment to avoid exacerbation, while the unregulated use of skin bleaching agents containing high-potency corticosteroids can pose serious health risks. Skin cancer in SOC often presents at advanced stages with poorer outcomes due to lower awareness and unique clinical manifestations, resulting in delayed diagnosis. Hair disorders in SOC populations require tailored diagnostic and therapeutic approaches due to unique hair properties. Gaps in photoprotection education on SOC exacerbate pigmentary disorders and other dermatologic conditions, with limited research on effective sunscreens for this population. In aesthetic dermatology, misconceptions and knowledge gaps regarding the prevention of complications hinder access to safe and effective procedures for SOC subjects, compounded by inadequate diversity in clinical trials. Inclusive research, improved diagnostic accuracy, and customized procedures are needed to ensure equitable dermatologic care.36:T7ef,ABSTRACT Patients with skin of color (SOC) face unique dermatologic challenges that are often underrepresented in research and in dermatological education, creating critical gaps in care. We aimed to identify and explore key gaps in research and clinical management for SOC across four domains: skin diseases, hair disorders, photoprotection, and aesthetic procedures. An international panel reviewed articles retrieved from PubMed using the search terms “skin of color” or “skin of colour” in titles and abstracts from September 2019 to September 2024. Inflammatory skin diseases, including acne, atopic dermatitis, psoriasis, and rosacea, are common in SOC subjects, necessitating tailored diagnostic and therapeutic approaches due to unique clinical presentations and specific challenges such as post‐inflammatory hyperpigmentation and erythema detection. Pigmentary disorders such as melasma and acne‐induced hyperpigmentation significantly impact quality of life in SOC, requiring cautious treatment to avoid exacerbation, while the unregulated use of skin bleaching agents containing high‐potency corticosteroids can pose serious health risks. Skin cancer in SOC often presents at advanced stages with poorer outcomes due to lower awareness and unique clinical manifestations, resulting in delayed diagnosis. Hair disorders in SOC populations require tailored diagnostic and therapeutic approaches due to unique hair properties. Gaps in photoprotection education on SOC exacerbate pigmentary disorders and other dermatologic conditions, with limited research on effective sunscreens for this population. In aesthetic dermatology, misconceptions and knowledge gaps regarding the prevention of complications hinder access to safe and effective procedures for SOC subjects, compounded by inadequate diversity in clinical trials. Inclusive research, improved diagnostic accuracy, and customized procedures are needed to ensure equitable dermatologic care.37:T487,The study included 1671 children (57.9% female; mean [SD] age, 13.7 [2.7] years). A total of 56.4% participants had self-reported high disease visibility and 50.5% had moderate disease severity. Stigma scores significantly differed by level of physician-assessed and child/proxy-assessed disease visibility and severity. Among children with chronic skin disorders, predominantly acne, atopic dermatitis, alopecia areata, and vitiligo, only 27.0% had T scores less than 40 (minimal or no stigma) and 43.8% had at least moderate stigma (T score ≥45) compared with children with a range of chronic diseases. Stigma scores correlated strongly with reduced QOL (Spearman ρ = 0.73), depression (ρ = 0.61), anxiety (ρ = 0.54), and poor peer relationships (ρ = -0.49). Overall, 29.4% of parents were aware of bullying of their child, which was strongly associated with stigma (Cohen d = -0.79, with children who were not bullied experiencing lower levels of stigma). Girls reported more stigma than boys (Cohen d = 0.26). Children with hyperhidrosis and hidradenitis suppurativa were most likely to have increased depression and anxiety.38:T9bd,Chronic skin disorders in children frequently are visible and can cause stigmatization. However, the extent of stigmatization from chronic skin disease and association with mental health needs further study. To examine the extent of stigma, dependence on disease visibility and severity, and association with mental health and quality of life (QOL) in chronic pediatric skin disease. A cross-sectional, single-visit study was conducted at 32 pediatric dermatology centers in the US and Canada from November 14, 2018, to November 17, 2021. Participants included patients aged 8 to 17 years with chronic skin disease and 1 parent. Using the Patient-Reported Outcomes Measurement Instrumentation System (PROMIS) Stigma-Skin, the extent of stigma with child-, caregiver-, and physician-assessed disease visibility (primary outcome) and severity was compared, as well as reduced QOL (assessed by Skindex-Teen), depression, anxiety, and poor peer relationships (PROMIS child and proxy tools) (secondary outcomes). The study included 1671 children (57.9% female; mean [SD] age, 13.7 [2.7] years). A total of 56.4% participants had self-reported high disease visibility and 50.5% had moderate disease severity. Stigma scores significantly differed by level of physician-assessed and child/proxy-assessed disease visibility and severity. Among children with chronic skin disorders, predominantly acne, atopic dermatitis, alopecia areata, and vitiligo, only 27.0% had T scores less than 40 (minimal or no stigma) and 43.8% had at least moderate stigma (T score ≥45) compared with children with a range of chronic diseases. Stigma scores correlated strongly with reduced QOL (Spearman ρ = 0.73), depression (ρ = 0.61), anxiety (ρ = 0.54), and poor peer relationships (ρ = -0.49). Overall, 29.4% of parents were aware of bullying of their child, which was strongly associated with stigma (Cohen d = -0.79, with children who were not bullied experiencing lower levels of stigma). Girls reported more stigma than boys (Cohen d = 0.26). Children with hyperhidrosis and hidradenitis suppurativa were most likely to have increased depression and anxiety. The findings of this study suggest that physician assessment of disease severity and visibility is insufficient to evaluate the disease impact in the patient/caregiver. Identifying stigmatization, including bullying, and tracking improvement through medical and psychosocial interventions may be a key role for practitioners.39:Tc52,ImportanceChronic skin disorders in children frequently are visible and can cause stigmatization. However, the extent of stigmatization from chronic skin disease and association with mental health needs further study.ObjectiveTo examine the extent of stigma, dependence on disease visibility and severity, and association with mental health and quality of life (QOL) in chronic pediatric skin disease.Design, Setting, and ParticipantsA cross-sectional, single-visit study was conducted at 32 pediatric dermatology centers in the US and Canada from November 14, 2018, to November 17, 2021. Participants included patients aged 8 to 17 years with chronic skin disease and 1 parent.Main Outcomes and MeasuresUsing the Patient-Reported Outcomes Measurement Instrumentation System (PROMIS) Stigma-Skin, the extent of stigma with child-, caregiver-, and physician-assessed disease visibility (primary outcome) and severity was compared, as well as reduced QOL (assessed by Skindex-Teen), depression, anxiety, and poor peer relationships (PROMIS child and proxy tools) (secondary outcomes).ResultsThe study included 1671 children (57.9% female; mean [SD] age, 13.7 [2.7] years). A total of 56.4% participants had self-reported high disease visibility and 50.5% had moderate disease severity. Stigma scores significantly differed by level of physician-assessed and child/proxy-assessed disease visibility and severity. Among children with chronic skin disorders, predominantly acne, atopic dermatitis, alopecia areata, and vitiligo, only 27.0% had T scores less than 40 (minimal or no stigma) and 43.8% had at least moderate stigma (T score ≥45) compared with children with a range of chronic diseases. Stigma scores correlated strongly with reduced QOL (Spearman ρ = 0.73), depression (ρ = 0.61), anxiety (ρ = 0.54), and poor peer relationships (ρ = −0.49). Overall, 29.4% of parents were aware of bullying of their child, which was strongly associated with stigma (Cohen d = −0.79, with children who were not bullied experiencing lower levels of stigma). Girls reported more stigma than boys (Cohen d = 0.26). Children with hyperhidrosis and hidradenitis suppurativa were most likely to have increased depression and anxiety.Conclusions and RelevanceThe findings of this study suggest that physician assessment of disease severity and visibility is insufficient to evaluate the disease impact in the patient/caregiver. Identifying stigmatization, including bullying, and tracking improvement through medical and psychosocial interventions may be a key role for practitioners.3a:T7a9,Dermatologists prescribe more oral antibiotics per clinician than clinicians in any other specialty. Despite clinical guidelines that recommend limitation of long-term oral antibiotic treatments for acne to less than 3 months, there is little evidence to guide the design and implementation of an antibiotic stewardship program in clinical practice. To identify salient barriers and facilitators to long-term antibiotic prescriptions for acne treatment. This qualitative study assessed data collected from stakeholders (including dermatologists, infectious disease physicians, dermatology resident physicians, and nonphysician clinicians) via an online survey and semistructured video interviews between March and August 2021. Data analyses were performed from August 12, 2021, to January 20, 2024. Online survey and qualitative video interviews developed with the Theoretical Domains Framework. Thematic analyses were used to identify salient themes on barriers and facilitators to long-term antibiotic prescriptions for acne treatment. Among 30 participants (14 [47%] males and 16 [53%] females) who completed the study requirements and were included in the analysis, knowledge of antibiotic guideline recommendations was high and antibiotic stewardship was believed to be a professional responsibility. Five salient themes were to be affecting long-term antibiotic prescriptions: perceived lack of evidence to justify change in dermatologic practice, difficulty navigating patient demands and satisfaction, discomfort with discussing contraception, iPLEDGE-related barriers, and the absence of an effective system to measure progress on antibiotic stewardship. The findings of this qualitative study indicate that multiple salient factors affect long-term antibiotic prescribing practices for acne treatment. These factors should be considered in the design and implementation of any future outpatient antibiotic stewardship program for clinical dermatology.3b:Ta04,ImportanceDermatologists prescribe more oral antibiotics per clinician than clinicians in any other specialty. Despite clinical guidelines that recommend limitation of long-term oral antibiotic treatments for acne to less than 3 months, there is little evidence to guide the design and implementation of an antibiotic stewardship program in clinical practice.ObjectiveTo identify salient barriers and facilitators to long-term antibiotic prescriptions for acne treatment.Design, Setting, and ParticipantsThis qualitative study assessed data collected from stakeholders (including dermatologists, infectious disease physicians, dermatology resident physicians, and nonphysician clinicians) via an online survey and semistructured video interviews between March and August 2021. Data analyses were performed from August 12, 2021, to January 20, 2024.Main Outcomes and MeasuresOnline survey and qualitative video interviews developed with the Theoretical Domains Framework. Thematic analyses were used to identify salient themes on barriers and facilitators to long-term antibiotic prescriptions for acne treatment.ResultsAmong 30 participants (14 [47%] males and 16 [53%] females) who completed the study requirements and were included in the analysis, knowledge of antibiotic guideline recommendations was high and antibiotic stewardship was believed to be a professional responsibility. Five salient themes were to be affecting long-term antibiotic prescriptions: perceived lack of evidence to justify change in dermatologic practice, difficulty navigating patient demands and satisfaction, discomfort with discussing contraception, iPLEDGE-related barriers, and the absence of an effective system to measure progress on antibiotic stewardship.Conclusions and RelevanceThe findings of this qualitative study indicate that multiple salient factors affect long-term antibiotic prescribing practices for acne treatment. These factors should be considered in the design and implementation of any future outpatient antibiotic stewardship program for clinical dermatology.3c:T459,A total of 32 participants were included in the study (mean [range] age, 32 [18-57] years; 17 transgender men, 11 transgender women, and 4 nonbinary participants). Ten participants (31%) self-rated their skin as currently clear or almost clear, 11 (34%) reported mild acne, and 11 (34%) had moderate to severe acne. Participants described experiences of rejection and bullying related to acne and admitted avoiding social interactions in which they anticipated acne-related discrimination, which led to feelings of depression and anxiety. Acne worsened body appearance dissatisfaction. Transgender women reported acne interfering with feminine gender expression. Transgender men often normalized acne development, sometimes viewing acne positively as an early sign of testosterone action. Most participants tried over-the-counter acne treatments and commonly sought acne treatment advice from physicians, peers, online forums, and social media. Barriers to acne treatments included cost, lack of multidisciplinary care, mistrust toward the health care system, and lack of transgender-specific acne care education.3d:Ta92,While acne is common in transgender and gender-diverse people and is associated with gender-affirming hormone therapy, little research has examined these factors and their impact in gender minority groups. To examine the lived experiences of acne and acne treatment in transgender and gender-diverse participants. This mixed-methods analysis was conducted at a multidisciplinary gender center at a public safety-net hospital and endocrinology and dermatology clinics at a tertiary academic center from January 4, 2021, to April 7, 2022, using semistructured interviews and surveys. Participants were transgender or gender-diverse adults who had received gender-affirming hormone therapy. Data analysis was performed from November 11, 2021, to March 31, 2023. Current diagnosis of acne. Interviews exploring the experience of acne and acne treatment were audio recorded, transcribed verbatim, coded using minority stress theory and the socioecological model, and analyzed using thematic analysis. Themes were triangulated with survey data on gender, self-reported acne severity, skin-specific quality-of-life impact, and treatment experience. A total of 32 participants were included in the study (mean [range] age, 32 [18-57] years; 17 transgender men, 11 transgender women, and 4 nonbinary participants). Ten participants (31%) self-rated their skin as currently clear or almost clear, 11 (34%) reported mild acne, and 11 (34%) had moderate to severe acne. Participants described experiences of rejection and bullying related to acne and admitted avoiding social interactions in which they anticipated acne-related discrimination, which led to feelings of depression and anxiety. Acne worsened body appearance dissatisfaction. Transgender women reported acne interfering with feminine gender expression. Transgender men often normalized acne development, sometimes viewing acne positively as an early sign of testosterone action. Most participants tried over-the-counter acne treatments and commonly sought acne treatment advice from physicians, peers, online forums, and social media. Barriers to acne treatments included cost, lack of multidisciplinary care, mistrust toward the health care system, and lack of transgender-specific acne care education. In this mixed-methods study, transgender and gender-diverse individuals reported experiencing acne-related stigma and facing barriers to acne treatment. Multilevel changes, such as developing strategies to reduce acne stigma, providing transgender-specific acne care education, facilitating multidisciplinary acne care, and expanding transgender-friendly clinical environments, are recommended to reduce the impact of acne in transgender individuals.3e:Td48,ImportanceWhile acne is common in transgender and gender-diverse people and is associated with gender-affirming hormone therapy, little research has examined these factors and their impact in gender minority groups.ObjectiveTo examine the lived experiences of acne and acne treatment in transgender and gender-diverse participants.Design, Setting, and ParticipantsThis mixed-methods analysis was conducted at a multidisciplinary gender center at a public safety-net hospital and endocrinology and dermatology clinics at a tertiary academic center from January 4, 2021, to April 7, 2022, using semistructured interviews and surveys. Participants were transgender or gender-diverse adults who had received gender-affirming hormone therapy. Data analysis was performed from November 11, 2021, to March 31, 2023.ExposureCurrent diagnosis of acne.Main Outcomes and MeasuresInterviews exploring the experience of acne and acne treatment were audio recorded, transcribed verbatim, coded using minority stress theory and the socioecological model, and analyzed using thematic analysis. Themes were triangulated with survey data on gender, self-reported acne severity, skin-specific quality-of-life impact, and treatment experience.ResultsA total of 32 participants were included in the study (mean [range] age, 32 [18-57] years; 17 transgender men, 11 transgender women, and 4 nonbinary participants). Ten participants (31%) self-rated their skin as currently clear or almost clear, 11 (34%) reported mild acne, and 11 (34%) had moderate to severe acne. Participants described experiences of rejection and bullying related to acne and admitted avoiding social interactions in which they anticipated acne-related discrimination, which led to feelings of depression and anxiety. Acne worsened body appearance dissatisfaction. Transgender women reported acne interfering with feminine gender expression. Transgender men often normalized acne development, sometimes viewing acne positively as an early sign of testosterone action. Most participants tried over-the-counter acne treatments and commonly sought acne treatment advice from physicians, peers, online forums, and social media. Barriers to acne treatments included cost, lack of multidisciplinary care, mistrust toward the health care system, and lack of transgender-specific acne care education.Conclusions and RelevanceIn this mixed-methods study, transgender and gender-diverse individuals reported experiencing acne-related stigma and facing barriers to acne treatment. Multilevel changes, such as developing strategies to reduce acne stigma, providing transgender-specific acne care education, facilitating multidisciplinary acne care, and expanding transgender-friendly clinical environments, are recommended to reduce the impact of acne in transgender individuals.25:[[["$","script","0",{"type":"application/ld+json","dangerouslySetInnerHTML":{"__html":"{\"@context\":\"https://schema.org\",\"@type\":\"CollectionPage\",\"name\":\"Acne: condition Research & Clinical Takeaways\",\"description\":\"Explore peer-reviewed papers on Acne (condition). Clinician-written summaries and actionable practice insights. Updated daily.\",\"url\":\"https://www.reachrx.ai/hub/tag/condition/Acne\",\"breadcrumb\":{\"@type\":\"BreadcrumbList\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https://www.reachrx.ai\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Hub\",\"item\":\"https://www.reachrx.ai/hub\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Conditions\",\"item\":\"https://www.reachrx.ai/hub/tag/condition\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Acne\",\"item\":\"https://www.reachrx.ai/hub/tag/condition/Acne\"}]}}"}}]],["$","$L2f",null,{"title":"Acne: Research & Clinical Takeaways","description":"Discover peer-reviewed research on Acne with concise clinician summaries and next-step guidance.","papers":[{"doi":"10.2340/actadv.v106.adv-2026-0668","pmid":"42658205","title":"Patient Expectations and Perceived Treatment Benefit in Dermatology: A Sex-specific Analysis in Routine Dermatological Care","journal_title":"Acta Dermato-Venereologica","journal_issn":"1651-2057","published_at":"2026-08-27T00:00:00.000Z","url":"https://doi.org/10.2340/actadv.v106.adv-2026-0668","source_score":1,"is_retracted":false,"is_open_access":true,"raw_metadata":{"pubmed":true,"crossref":true,"unpaywall":true},"created_at":"2026-09-05T06:20:19.612Z","updated_at":"2026-09-05T06:20:19.612Z","tags":[{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"condition","value":"Allergic Skin Disease","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"condition","value":"Hidradenitis Suppurativa","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"condition","value":"Inflammatory Skin Disease","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"condition","value":"Rosacea","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"condition","value":"Skin Cancer","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"level_of_evidence","value":"4","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"sample_size","value":"n=460","value_numeric":460},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"study_design","value":"Cross-Sectional Study","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"warning","value":"Sex was recorded as a binary self-reported variable; the paper explicitly notes it refers to biological sex, so findings may not apply to gender-diverse populations.","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"warning","value":"The study is described as 'hypothesis-generating' by the authors themselves; results should not be used to change practice without confirmatory multivariable evidence.","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"warning","value":"The study used a convenience sample with no a-priori power calculation, so effect estimates may be imprecise. The convenience sample design and single-center setting limit generalizability.","value_numeric":null},{"paper_doi":"10.2340/actadv.v106.adv-2026-0668","tag_type":"warning","value":"Univariable sex comparisons were not adjusted for age (mean difference ~4 years between groups), disease severity, or diagnosis mix, which could confound the observed differences.","value_numeric":null}],"summaries":{"what_studied":"This cross-sectional study examined sex differences in treatment expectations (PNQ), perceived treatment benefit (PBQ), and the expectation–benefit gap using the Patient Benefit Index (PBI) in 460 adult dermatology outpatients (232 male, 228 female; mean age 52.1 years) at a single German academic center between February 2024 and February 2026.","key_result":"Women reported higher treatment expectations than men across all 25 items (13/25 significant after Bonferroni correction), with the largest gaps for lower treatment costs (male 3.21 vs female 3.96, p<0.001) and fewer side-effects (3.66 vs 4.28, p<0.001). Despite comparable perceived benefit between sexes, the expectation–benefit gap was significant for 24/25 items in women (effect sizes r=0.69–0.82) versus only 10/25 in men, with women's largest gaps for healed skin (Δ=1.43) and regaining control (Δ=1.08).","limitations":"- The expectation–benefit gap was derived cross-sectionally (not a prospective disconfirmation design), so it reflects a retrospective discrepancy score, not a validated longitudinal measure.\n- Sex comparisons were univariable and unadjusted for confounders such as age, disease severity, or diagnosis.\n- The cohort was dominated by inflammatory skin diseases (65.1%), limiting generalizability to non-inflammatory or more homogeneous dermatological populations.","practice_takeaway":"Women in dermatology consistently enter treatment with higher expectations than men but perceive similar benefit, creating a large unmet-expectations gap — clinicians should proactively discuss realistic treatment goals with female patients at the start of care. Addressing this gap explicitly may improve satisfaction and adherence, since unmet expectations — not just insufficient efficacy — can drive perceived treatment failure."}},{"doi":"10.1111/jdv.70562","pmid":"42324974","title":"The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data","journal_title":"Journal of the European Academy of Dermatology and Venereology","journal_issn":"0926-9959","published_at":"2026-06-22T00:00:00.000Z","url":"https://doi.org/10.1111/jdv.70562","source_score":7,"is_retracted":false,"is_open_access":true,"raw_metadata":{"pubmed":true,"crossref":true,"unpaywall":true},"created_at":"2026-06-28T13:27:20.921Z","updated_at":"2026-06-28T13:27:20.921Z","tags":[{"paper_doi":"10.1111/jdv.70562","tag_type":"age_group","value":"mixed","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Atopic Dermatitis","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Basal Cell Carcinoma","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Contact Dermatitis","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Decubitus Ulcer","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Fungal Skin Infections","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Scabies","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Sexually Transmitted Infections","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Skin and Subcutaneous Diseases","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"condition","value":"Squamous Cell Carcinoma","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"impact_flag","value":"confirms_prior","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"study_design","value":"Cross-Sectional / Epidemiological Analysis","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"warning","value":"Level of evidence assigned as 3 (epidemiological/cross-sectional analysis of registry data); some may classify GBD analyses differently depending on institutional hierarchy frameworks.","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"warning","value":"Study design is a secondary analysis of GBD aggregate data — no primary patient-level data collected; causality cannot be inferred.","value_numeric":null},{"paper_doi":"10.1111/jdv.70562","tag_type":"warning","value":"The 25.7% prevalence figure explicitly excludes STIs and skin cancers, so direct comparisons with other overall skin disease burden estimates require caution.","value_numeric":null}],"summaries":{"what_studied":"Global epidemiology and disease burden of skin diseases using GBD 2021 data (2000–2021), including prevalence, incidence, DALYs, and YLDs across demographics and regions — excluding sexually transmitted infections (STIs) and skin cancers from the primary burden category.","key_result":"Skin and subcutaneous diseases (excluding STIs and skin cancers) affected 25.7% of the global population, ranking 6th in prevalence and 8th in YLDs (495.1 per 100,000 person-years). The most prevalent conditions overall were STIs excluding HIV (16.8%), fungal infections (7.8%), and acne (3.0%). Squamous cell carcinoma, basal cell carcinoma, and decubitus ulcers are rising; atopic dermatitis, scabies, and viral infections are declining slightly.","limitations":"- GBD captures only a subset of dermatological conditions, likely underestimating true burden due to widespread underreporting and misdiagnosis.\n- Major data gaps exist for low- and middle-income countries.\n- Quality-adjusted life year estimates do not adequately account for cultural and social variation.","practice_takeaway":"Skin diseases affect roughly 1 in 3 people globally, with infectious conditions dominating in Sub-Saharan Africa and tropical regions, while chronic inflammatory diseases and skin cancers predominate in high-income countries — clinicians should tailor screening and management to regional burden profiles. The true burden is likely higher than GBD figures suggest, underscoring the need for improved reporting, especially in resource-limited settings."}},{"doi":"10.1001/jamadermatol.2026.0916","pmid":"42090138","title":"Pediatric Skin Disease Frequencies and Dermatology Use by Race and Ethnicity in US Children’s Hospitals","journal_title":"JAMA Dermatology","journal_issn":"2168-6068","published_at":"2026-05-06T00:00:00.000Z","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13150731/","source_score":10,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2026-05-11","doi":"10.1001/jamadermatol.2026.0916","days":"7","issn":"2168-6068","rank":"4","field":"Clinical Medicine","score":"10","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1001/jamadermatol.2026.0916","title":"Pediatric Skin Disease Frequencies and Dermatology Use by Race and Ethnicity in US Children's Hospitals.","journal":"JAMA dermatology","methods":"","results":"Of 536 776 patients, the mean (SD) age was 6.4 (6.3) years, 51.5% were female, and 0.2% were American Indian or Alaska Native, 6.4% Asian, 27.9% Black, 14.1% Hispanic, 0.3% Native Hawaiian or Other Pacific Islander, 8.4% non-Hispanic, 44.3% White, 4.3% multiple races, 5.5% unknown ethnicity, and 16.6% unknown race. Case counts were 377 970 for AD, 139 632 for acne, 54 305 for infantile hemangioma, 11 339 for psoriasis, and 5722 for HS. Electronic health record-derived frequencies varied across race and ethnicity groups. There were 10 469 (95% CI, 10 414-10 524) cases of AD per 100 000 Black children compared with 3099 (95% CI, 3083-3114) per 100 000 White children. There were 290 (95% CI, 280-300) cases of infantile hemangioma per 100 000 Black children compared with 764 (95% CI, 756-772) per 100 000 White children. Black children had a low proportion of dermatology use across all 5 conditions, yet high frequencies of AD, acne, and HS.","abstract":"$30","keywords":[],"pubmed_id":"42090138","conclusions":"","publication_date":"2026-05-06T00:00:00"},"crossref":{"DOI":"10.1001/jamadermatol.2026.0916","URL":"https://doi.org/10.1001/jamadermatol.2026.0916","ISSN":["2168-6068"],"link":[{"URL":"https://jamanetwork.com/journals/jamadermatology/articlepdf/2848387/jamadermatology_quan_2026_oi_260013_1777558592.59238.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":null,"type":"journal-article","issue":null,"score":1,"title":["Pediatric Skin Disease Frequencies and Dermatology Use by Race and Ethnicity in US Children’s Hospitals"],"author":[{"given":"Nicolas G.","family":"Quan","sequence":"first","affiliation":[{"name":"Department of Dermatology, University of Colorado, Aurora"}]},{"given":"Elizabeth","family":"Garcia-Creighton","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Colorado, Aurora"}]},{"given":"Molly","family":"Thapar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Colorado, Aurora"}]},{"given":"Briana","family":"Kille","sequence":"additional","affiliation":[{"name":"Department of Research Informatics & Data Science, Children’s Hospital Colorado, Aurora"}]},{"given":"Josh","family":"Tucker","sequence":"additional","affiliation":[{"name":"Department of Research Informatics & Data Science, Children’s Hospital Colorado, Aurora"}]},{"given":"Sarah J.","family":"Schmiege","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora"}]},{"given":"Markus D.","family":"Boos","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Pediatrics, University of Washington School of Medicine and Seattle Children’s Hospital, Seattle"}]},{"given":"Esteban","family":"Fernández Faith","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Pediatrics, Nationwide Children’s Hospital, The Ohio State University College of Medicine, Columbus"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"},{"name":"Department of Dermatology, Ann and Robert H. Lurie Children’s Hospital, Chicago, Illinois"}]},{"given":"Dawn H.","family":"Siegel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University School of Medicine, Palo Alto, California"},{"name":"Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California"}]},{"given":"Liza H.","family":"Siegel","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri"}]},{"given":"Roslyn T.","family":"Varki","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Pediatrics, Nemours Children’s Health System, Wilmington, Delaware"}]},{"given":"Albert C.","family":"Yan","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics and Dermatology, Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania"}]},{"given":"Lucinda L.","family":"Kohn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Colorado, Aurora"}]}],"issued":{"date-parts":[[2026,5,6]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":null,"created":{"date-time":"2026-05-06T15:31:43Z","timestamp":1778081503000,"date-parts":[[2026,5,6]]},"indexed":{"date-time":"2026-05-06T16:14:39Z","timestamp":1778084079008,"date-parts":[[2026,5,6]]},"subject":[],"abstract":"$31","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamadermatology/fullarticle/2848387"}},"subtitle":[],"deposited":{"date-time":"2026-05-06T15:31:44Z","timestamp":1778081504000,"date-parts":[[2026,5,6]]},"issn-type":[{"type":"print","value":"2168-6068"}],"published":{"date-parts":[[2026,5,6]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1016/j.acap.2025.102835","key":"doi260013r1","year":"2025","issue":"6","author":"Lee","volume":"25","first-page":null,"unstructured":null,"article-title":"Geographic maldistribution of pediatric dermatologists in relation to pediatric and family medicine residency programs.","journal-title":"Acad Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.14748","key":"doi260013r2","year":"2021","issue":null,"author":"Toy","volume":"38","first-page":"13","unstructured":null,"article-title":"Barriers to healthcare access in pediatric dermatology: a systematic review.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.15914","key":"doi260013r3","year":"2025","issue":"3","author":"Gottlieb","volume":"42","first-page":"457","unstructured":null,"article-title":"An updated scoping review of disparities in pediatric atopic dermatitis.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1093/bjd/ljae322","key":"doi260013r4","year":"2024","issue":"1","author":"Servattalab","volume":"192","first-page":"144","unstructured":null,"article-title":"Examining racial and ethnic disparities in diagnosis and access to care in infantile atopic dermatitis in the USA: a retrospective cohort study.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.14755","key":"doi260013r5","year":"2021","issue":null,"author":"Kuo","volume":"38","first-page":"6","unstructured":null,"article-title":"A systematic scoping review of racial, ethnic, and socioeconomic health disparities in pediatric dermatology.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.08.007","key":"doi260013r6","year":"2023","issue":"6","author":"Beiter","volume":"89","first-page":"1273","unstructured":null,"article-title":"Consideration of social context in understanding health disparities in pediatric dermatology.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2021.09.018","key":"doi260013r7","year":"2022","issue":"2","author":"Bajwa","volume":"86","first-page":"399","unstructured":null,"article-title":"Mixed evidence on the relationship between socioeconomic position and atopic dermatitis: a systematic review.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.15455","key":"doi260013r8","year":"2023","issue":"6","author":"Reimer-Taschenbrecker","volume":"40","first-page":"1049","unstructured":null,"article-title":"Do socioeconomic factors impact atopic dermatitis outcome? A single-center study.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaci.2023.11.013","key":"doi260013r9","year":"2024","issue":"4","author":"Croce","volume":"153","first-page":"1140","unstructured":null,"article-title":"Lower socioeconomic status may help explain racial disparities in asthma and atopic dermatitis prevalence: a mediation analysis.","journal-title":"J Allergy Clin Immunol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2018.09.041","key":"doi260013r10","year":"2023","issue":"5","author":"Lie","volume":"88","first-page":"e221","unstructured":null,"article-title":"Lower socioeconomic status is associated with delayed access to care for infantile hemangioma: a cohort study.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamanetworkopen.2025.15094","key":"doi260013r11","year":"2025","issue":"6","author":"Sitarik","volume":"8","first-page":null,"unstructured":null,"article-title":"Phenotypes of atopic dermatitis and development of allergic diseases.","journal-title":"JAMA Netw Open","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.15387","key":"doi260013r12","year":"2023","issue":"5","author":"Noveir","volume":"40","first-page":"829","unstructured":null,"article-title":"Patterns and determinants of pediatric dermatologic care in the United States: an evaluation of the National Ambulatory Medical Care Survey from 2009 to 2015.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jid.2018.04.001","key":"doi260013r13","year":"2018","issue":"10","author":"Garg","volume":"138","first-page":"2152","unstructured":null,"article-title":"Prevalence estimates for hidradenitis suppurativa among children and adolescents in the United States: a gender- and age-adjusted population analysis.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi260013r14","year":"2023","issue":"459","author":"Zablotsky","volume":null,"first-page":"1","unstructured":null,"article-title":"Diagnosed allergic conditions in children aged 0-17 years: United States, 2021.","journal-title":"NCHS Data Brief","doi-asserted-by":null},{"DOI":"10.1111/pde.12075","key":"doi260013r15","year":"2013","issue":"4","author":"Amrock","volume":"30","first-page":"493","unstructured":null,"article-title":"Diverging racial trends in neonatal infantile hemangioma diagnoses, 1979-2006.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/ijd.15805","key":"doi260013r16","year":"2022","issue":"6","author":"Monir","volume":"61","first-page":"727","unstructured":null,"article-title":"Association between atopic dermatitis and race from infancy to early childhood: a retrospective cohort study.","journal-title":"Int J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2020.5434","key":"doi260013r17","year":"2021","issue":"4","author":"Kirby","volume":"157","first-page":"379","unstructured":null,"article-title":"Recognizing the effects and disparities of pediatric hidradenitis suppurativa.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1136/amiajnl-2014-002743","key":"doi260013r18","year":"2014","issue":"4","author":"Forrest","volume":"21","first-page":"602","unstructured":null,"article-title":"PEDSnet: a National Pediatric Learning Health System.","journal-title":"J Am Med Inform Assoc","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2022.0351","key":"doi260013r19","year":"2022","issue":"5","author":"McKenzie","volume":"158","first-page":"547","unstructured":null,"article-title":"Evaluation of the prevalence and incidence of pediatric alopecia areata using electronic health record data.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1002/pds.5229","key":"doi260013r20","year":"2021","issue":"7","author":"Lee","volume":"30","first-page":"868","unstructured":null,"article-title":"Validation of claims-based algorithms to identify patients with psoriasis.","journal-title":"Pharmacoepidemiol Drug Saf","doi-asserted-by":"publisher"},{"DOI":"10.1111/j.1365-2133.2010.10134.x","key":"doi260013r21","year":"2011","issue":"3","author":"Seminara","volume":"164","first-page":"602","unstructured":null,"article-title":"Validity of The Health Improvement Network (THIN) for the study of psoriasis.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2018.3114","key":"doi260013r22","year":"2018","issue":"11","author":"Tripathi","volume":"154","first-page":"1286","unstructured":null,"article-title":"Association of demographic and socioeconomic characteristics with differences in use of outpatient dermatology services in the United States.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.5070/D329160207","key":"doi260013r23","year":"2023","issue":"1","author":"Zagona-Prizio","volume":"29","first-page":null,"unstructured":null,"article-title":"Differences in accessing dermatology offices, primary care offices, and emergency departments between Hispanics and non-Hispanic White patients.","journal-title":"Dermatol Online J","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2017.08.035","key":"doi260013r24","year":"2017","issue":"6","author":"Fischer","volume":"77","first-page":"1060","unstructured":null,"article-title":"Racial and ethnic differences in health care utilization for childhood eczema: an analysis of the 2001-2013 Medical Expenditure Panel Surveys.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2024.01.067","key":"doi260013r25","year":"2024","issue":"6","author":"Harvey","volume":"91","first-page":"1189","unstructured":null,"article-title":"Integrating skin color assessments into clinical practice and research: a review of current approaches.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2014.06.032","key":"doi260013r26","year":"2014","issue":"4","author":"Feigenbaum","volume":"71","first-page":"656","unstructured":null,"article-title":"What should primary care providers know about pediatric skin conditions? A modified Delphi technique for curriculum development.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaip.2023.03.041","key":"doi260013r27","year":"2023","issue":"5","author":"Davis","volume":"11","first-page":"1376","unstructured":null,"article-title":"Managing atopic dermatitis in patients with skin of color.","journal-title":"J Allergy Clin Immunol Pract","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.12703","key":"doi260013r28","year":"2015","issue":"6","author":"Fogel","volume":"32","first-page":"e314","unstructured":null,"article-title":"A survey to assess perceived differences in referral pathways to board-certified pediatric dermatologists.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.pedhc.2024.02.001","key":"doi260013r29","year":"2024","issue":"5","author":"Kozy","volume":"38","first-page":"651","unstructured":null,"article-title":"Referral patterns and diagnostic concordance in pediatric skin disorders.","journal-title":"J Pediatr Health Care","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.003","key":"doi260013r30","year":"2023","issue":"3","author":"Adawi","volume":"41","first-page":"417","unstructured":null,"article-title":"Diagnosing atopic dermatitis in skin of color.","journal-title":"Dermatol Clin","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11606-023-08392-0","key":"doi260013r31","year":"2023","issue":"14","author":"Anderson","volume":"38","first-page":"3247","unstructured":null,"article-title":"The bias of medicine in sickle cell disease.","journal-title":"J Gen Intern Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jpainsymman.2014.02.002","key":"doi260013r32","year":"2014","issue":"5","author":"Haywood","volume":"48","first-page":"934","unstructured":null,"article-title":"Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease.","journal-title":"J Pain Symptom Manage","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11606-020-06336-6","key":"doi260013r33","year":"2022","issue":"2","author":"Schulson","volume":"37","first-page":"472","unstructured":null,"article-title":"National estimates of professional interpreter use in the ambulatory setting.","journal-title":"J Gen Intern Med","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi260013r34","year":"2016","issue":"1","author":"Brooks","volume":"99","first-page":"30","unstructured":null,"article-title":"Patient perspectives on the need for and barriers to professional medical interpretation.","journal-title":"R I Med J (2013)","doi-asserted-by":null},{"DOI":"10.1001/archpediatrics.2008.521","key":"doi260013r35","year":"2009","issue":"2","author":"Rajakumar","volume":"163","first-page":"108","unstructured":null,"article-title":"Racial differences in parents’ distrust of medicine and research.","journal-title":"Arch Pediatr Adolesc Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jid.2019.02.024","key":"doi260013r36","year":"2019","issue":"9","author":"Wan","volume":"139","first-page":"1906","unstructured":null,"article-title":"Racial/ethnic variation in use of ambulatory and emergency care for atopic dermatitis among US children.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.16021","key":"doi260013r37","year":"2025","issue":"5","author":"Thapar","volume":"42","first-page":"971","unstructured":null,"article-title":"What matters most to minoritized families in pediatric dermatology care: a qualitative study.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamahealthforum.2022.1398","key":"doi260013r38","year":"2022","issue":"6","author":"Wallace","volume":"3","first-page":null,"unstructured":null,"article-title":"Disparities in health care spending and utilization among Black and White Medicaid enrollees.","journal-title":"JAMA Health Forum","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamanetworkopen.2024.31073","key":"doi260013r40","year":"2024","issue":"9","author":"Freed","volume":"7","first-page":null,"unstructured":null,"article-title":"Error rates in race and ethnicity designation across large pediatric health systems.","journal-title":"JAMA Netw Open","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.15891","key":"doi260013r41","year":"2025","issue":"4","author":"Onamusi","volume":"42","first-page":"806","unstructured":null,"article-title":"Racial differences in disease characteristics of pediatric hidradenitis suppurativa.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jpeds.2023.113485","key":"doi260013r42","year":"2023","issue":null,"author":"Srinivasan","volume":"260","first-page":null,"unstructured":null,"article-title":"Disparities in pediatric specialty referral scheduling and completion.","journal-title":"J Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2023.2008","key":"doi260013r43","year":"2023","issue":"8","author":"Long","volume":"159","first-page":"811","unstructured":null,"article-title":"Understanding discordant perceptions of disease severity between physicians and patients with eczema and psoriasis using structural equation modeling.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jpeds.2025.114604","key":"doi260013r44","year":"2025","issue":null,"author":"Yamamoto","volume":"283","first-page":null,"unstructured":null,"article-title":"Emergency versus outpatient care for pediatric atopic dermatitis: a population-based study of sociodemographic factors and health care utilization.","journal-title":"J Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2021.2865","key":"doi260013r45","year":"2021","issue":"9","author":"Hallock","volume":"157","first-page":"1095","unstructured":null,"article-title":"Differences between children and adults with hidradenitis suppurativa.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s00403-024-03250-3","key":"doi260013r46","year":"2024","issue":"9","author":"Singal","volume":"316","first-page":"616","unstructured":null,"article-title":"Hidradenitis suppurativa in Black pediatric patients—a national analysis of the Kids’ Inpatient Database.","journal-title":"Arch Dermatol Res","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.pedn.2024.05.001","key":"doi260013r47","year":"2024","issue":null,"author":"Vestal","volume":"77","first-page":"e385","unstructured":null,"article-title":"Barriers and facilitators to accessing pediatric specialty care for rural-dwelling children with complex chronic conditions: an integrative review.","journal-title":"J Pediatr Nurs","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jpeds.2012.07.022","key":"doi260013r48","year":"2013","issue":"2","author":"Zuckerman","volume":"162","first-page":"409","unstructured":null,"article-title":"Barriers to specialty care and specialty referral completion in the community health center setting.","journal-title":"J Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1186/s12887-023-04400-8","key":"doi260013r49","year":"2023","issue":"1","author":"Bohnhoff","volume":"23","first-page":"576","unstructured":null,"article-title":"General and subspecialist pediatrician perspectives on barriers and strategies for referral: a latent profile analysis.","journal-title":"BMC Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1377/hlthaff.2021.01409","key":"doi260013r50","year":"2022","issue":"2","author":"Eberth","volume":"41","first-page":"237","unstructured":null,"article-title":"The problem of the color line: spatial access to hospital services for minoritized racial and ethnic groups.","journal-title":"Health Aff (Millwood)","doi-asserted-by":"publisher"},{"DOI":"10.2196/67728","key":"doi260013r51","year":"2025","issue":null,"author":"McDowell","volume":"8","first-page":null,"unstructured":null,"article-title":"Provider perspectives on pediatric store-and-forward teledermatology at Boston Medical Center: cross-sectional survey.","journal-title":"JMIR Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.14762","key":"doi260013r52","year":"2021","issue":null,"author":"Rehmus","volume":"38","first-page":"174","unstructured":null,"article-title":"Integrating dermatology services into a social pediatrics network: 8 years of experience in the RICHER (Responsive, Interdisciplinary/Intersectoral, Child/Community, Health, Education and Research) program.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.15698","key":"doi260013r53","year":"2024","issue":"6","author":"Crockett","volume":"41","first-page":"1114","unstructured":null,"article-title":"Pediatric dermatology eConsultation: insights to reduce barriers to utilization and increase access to care.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jdrv.2024.12.004","key":"doi260013r54","year":"2025","issue":null,"author":"Proffer","volume":"3","first-page":"60","unstructured":null,"article-title":"Disparities in specialty care: a review of US nonprofit initiatives.","journal-title":"JAAD Reviews","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2020.09.019","key":"doi260013r55","year":"2021","issue":"3","author":"Franciosi","volume":"84","first-page":"769","unstructured":null,"article-title":"Understanding the impact of teledermatology on no-show rates and health care accessibility: a retrospective chart review.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi260013r39","year":"2024","issue":null,"author":"Garcia-Creighton","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Dermatology"],"reference-count":55,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2026,5,6]]},"references-count":55,"short-container-title":["JAMA Dermatol"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1001/jamadermatol.2026.0916","is_oa":true,"title":"Pediatric Skin Disease Frequencies and Dermatology Use by Race and Ethnicity in US Children’s Hospitals","updated":"2026-05-12T08:54:10+00:00","published_date":"2026-05-06","best_oa_location":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13150731/","pmh_id":"oai:pubmedcentral.nih.gov:13150731","url_for_pdf":null,"url_for_landing_page":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13150731/"}}},"created_at":"2026-05-12T13:18:03.403Z","updated_at":"2026-05-14T15:13:26.918Z","tags":[{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"age_group","value":"pediatric","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"condition","value":"Atopic Dermatitis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"condition","value":"Hidradenitis Suppurativa","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"condition","value":"Infantile Hemangioma","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"condition","value":"Psoriasis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"impact_flag","value":"safety_signal","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"sample_size","value":"n=536776","value_numeric":536776},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"study_design","value":"Cross-Sectional Study","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"warning","value":"Full text is under embargo until May 2027; summary is based solely on the abstract and results excerpt — detailed methodology, adjusted analyses, and per-condition dermatology use rates by race/ethnicity are not available for review.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"warning","value":"impact_flag set to 'safety_signal' to highlight the potential care gap for Black children, though the authors note further research is needed to confirm whether this represents a true gap versus appropriate care routing.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2026.0916","tag_type":"warning","value":"The 'non-Hispanic' category (8.4%) appears to be listed separately from White (44.3%), suggesting possible ambiguity or overlap in how race and ethnicity were coded in the EHR data.","value_numeric":null}],"summaries":{"what_studied":"This multicenter cross-sectional study examined the frequency of 5 pediatric skin conditions (atopic dermatitis, acne, infantile hemangioma, psoriasis, and hidradenitis suppurativa) and rates of dermatology specialty care use, stratified by race and ethnicity, across 8 US children's hospitals in the PEDSnet system from January 2009 to July 2022.","key_result":"Among 536,776 children, Black children had the highest EHR-derived frequency of atopic dermatitis (10,469 per 100,000 vs. 3,099 per 100,000 White children) and the lowest frequency of infantile hemangioma (290 vs. 764 per 100,000 White children), yet had a low proportion of dermatology specialty care use across all 5 conditions despite high frequencies of AD, acne, and HS.","limitations":"- EHR-derived diagnoses may reflect coding practices and access to care rather than true disease prevalence.\n- Study limited to children's hospital networks (PEDSnet), which may not represent community or primary care settings.\n- It is unclear whether lower dermatology use in Black children reflects appropriate care routing or actual gaps in specialty access.","practice_takeaway":"Black children carry a disproportionately high burden of atopic dermatitis, acne, and hidradenitis suppurativa but are less likely to reach pediatric dermatology care — clinicians should actively consider referral pathways and potential access barriers for these patients."}},{"doi":"10.1001/jamadermatol.2025.5163","pmid":"41432938","title":"Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases","journal_title":"JAMA Dermatology","journal_issn":"2168-6068","published_at":"2025-12-23T00:00:00.000Z","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12728729/","source_score":26,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2025-12-25","doi":"10.1001/jamadermatol.2025.5163","days":"30","issn":"2168-6068","rank":"4","field":"Clinical Medicine","score":"26","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1001/jamadermatol.2025.5163","title":"Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases.","journal":"JAMA dermatology","methods":"","results":"$32","abstract":"$33","keywords":[],"pubmed_id":"41432938","conclusions":"","publication_date":"2025-12-23T00:00:00"},"crossref":{"DOI":"10.1001/jamadermatol.2025.5163","URL":"https://doi.org/10.1001/jamadermatol.2025.5163","ISSN":["2168-6068"],"link":[{"URL":"https://jamanetwork.com/journals/jamadermatology/articlepdf/2842851/jamadermatology_nock_2025_oi_250063_1765296580.48453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":null,"type":"journal-article","issue":null,"score":1,"title":["Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases"],"author":[{"given":"Michael R.","family":"Nock","sequence":"first","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut"}]},{"given":"Sherry","family":"Ershadi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"}]},{"given":"Abizairie","family":"Sánchez-Feliciano","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"}]},{"given":"Anissa Valentina","family":"Amstutz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"}]},{"given":"David J.","family":"Margolis","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia"}]},{"given":"Andrea L.","family":"Pusic","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Brigham and Women’s Hospital, Boston, Massachusetts"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Associate Editor, JAMA Dermatology"}]}],"issued":{"date-parts":[[2025,12,23]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":null,"created":{"date-time":"2025-12-23T16:00:46Z","timestamp":1766505646000,"date-parts":[[2025,12,23]]},"indexed":{"date-time":"2025-12-23T16:57:25Z","timestamp":1766509045216,"date-parts":[[2025,12,23]]},"subject":[],"abstract":"$34","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamadermatology/fullarticle/2842851"}},"subtitle":[],"deposited":{"date-time":"2025-12-23T16:00:48Z","timestamp":1766505648000,"date-parts":[[2025,12,23]]},"issn-type":[{"type":"print","value":"2168-6068"}],"published":{"date-parts":[[2025,12,23]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1016/j.jid.2022.01.008","key":"doi250063r1","year":"2022","issue":"6","author":"Secrest","volume":"142","first-page":"1529","unstructured":null,"article-title":"Incorporating patient-reported outcomes as a vital sign for dermatologic clinical care and clinical investigations.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257-023-00758-8","key":"doi250063r2","year":"2023","issue":"4","author":"Snyder","volume":"24","first-page":"499","unstructured":null,"article-title":"Patient-reported outcome measures and their clinical applications in dermatology.","journal-title":"Am J Clin Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2024.1281","key":"doi250063r3","year":"2024","issue":"8","author":"Hopkins","volume":"160","first-page":"801","unstructured":null,"article-title":"Validating patient-reported outcome measures in dermatology.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2021.3341","key":"doi250063r4","year":"2021","issue":"10","author":"Barbieri","volume":"157","first-page":"1236","unstructured":null,"article-title":"Patient-reported outcome measures as complementary information to clinician-reported outcome measures in patients with psoriasis.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11136-021-03030-w","key":"doi250063r5","year":"2022","issue":"6","author":"Taliercio","volume":"31","first-page":"1719","unstructured":null,"article-title":"Clinicians’ perspectives on the integration of electronic patient-reported outcomes into dermatology clinics: a qualitative study.","journal-title":"Qual Life Res","doi-asserted-by":"publisher"},{"DOI":"10.1002/jmrs.421","key":"doi250063r6","year":"2021","issue":"2","author":"Nguyen","volume":"68","first-page":"186","unstructured":null,"article-title":"A review of the barriers to using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine cancer care.","journal-title":"J Med Radiat Sci","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jid.2019.12.017","key":"doi250063r7","year":"2020","issue":"5","author":"Terwee","volume":"140","first-page":"1089","unstructured":null,"article-title":"The value of item banks, CAT, and PROMIS for dermatology.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2023.6245","key":"doi250063r8","year":"2024","issue":"4","author":"Shields","volume":"160","first-page":"441","unstructured":null,"article-title":"Identifying core outcome domains in chronic skin disease using the best-worst scaling method.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s00403-020-02074-1","key":"doi250063r10","year":"2021","issue":"1","author":"Esaa","volume":"313","first-page":"17","unstructured":null,"article-title":"The utility of PROMIS domain measures in dermatologic care.","journal-title":"Arch Dermatol Res","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.18978","key":"doi250063r11","year":"2020","issue":"5","author":"Silverberg","volume":"183","first-page":"891","unstructured":null,"article-title":"Measurement properties of the Patient-Reported Outcomes Information System (PROMIS®) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jid.2019.08.452","key":"doi250063r12","year":"2020","issue":"5","author":"Silverberg","volume":"140","first-page":"986","unstructured":null,"article-title":"Development, validation, and interpretation of the PROMIS Itch Questionnaire: a patient-reported outcome measure for the quality of life impact of itch.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2019.11.057","key":"doi250063r13","year":"2020","issue":"5","author":"Silverberg","volume":"82","first-page":"1174","unstructured":null,"article-title":"Measurement properties of the Patient-Reported Outcomes Measurement Information System Itch Questionnaire item banks in adults with atopic dermatitis.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jid.2021.10.015","key":"doi250063r14","year":"2022","issue":"5","author":"Paller","volume":"142","first-page":"1309","unstructured":null,"article-title":"Generation and validation of the Patient-Reported Outcome Measurement Information System Itch Questionnaire-Child (PIQ-C) to measure the impact of itch on life quality.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.18920","key":"doi250063r15","year":"2020","issue":"5","author":"Lei","volume":"183","first-page":"875","unstructured":null,"article-title":"Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in adults with atopic dermatitis.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2020.05.138","key":"doi250063r16","year":"2023","issue":"2","author":"Fishbein","volume":"88","first-page":"348","unstructured":null,"article-title":"Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.clinthera.2014.04.006","key":"doi250063r17","year":"2014","issue":"5","author":"Cappelleri","volume":"36","first-page":"648","unstructured":null,"article-title":"Overview of classical test theory and item response theory for the quantitative assessment of items in developing patient-reported outcomes measures.","journal-title":"Clin Ther","doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257-019-00496-w","key":"doi250063r24","year":"2020","issue":"3","author":"Perez-Chada","volume":"21","first-page":"323","unstructured":null,"article-title":"Investigator and patient global assessment measures for psoriasis clinical trials: a systematic review on measurement properties from the International Dermatology Outcome Measures (IDEOM) Initiative.","journal-title":"Am J Clin Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11136-024-03761-6","key":"doi250063r25","year":"2024","issue":"11","author":"Mokkink","volume":"33","first-page":"2929","unstructured":null,"article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures version 2.0.","journal-title":"Qual Life Res","doi-asserted-by":"publisher"},{"DOI":"10.1111/j.1365-2133.2008.08832.x","key":"doi250063r26","year":"2008","issue":"5","author":"Basra","volume":"159","first-page":"997","unstructured":null,"article-title":"The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jclinepi.2006.03.012","key":"doi250063r27","year":"2007","issue":"1","author":"Terwee","volume":"60","first-page":"34","unstructured":null,"article-title":"Quality criteria were proposed for measurement properties of health status questionnaires.","journal-title":"J Clin Epidemiol","doi-asserted-by":"publisher"},{"DOI":"10.1177/0049124114543236","key":"doi250063r28","year":"2015","issue":"3","author":"Kenny","volume":"44","first-page":"486","unstructured":null,"article-title":"The performance of RMSEA in models with small degrees of freedom.","journal-title":"Sociol Methods Res","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi250063r29","year":"2016","issue":"3","author":"Taasoobshirazi","volume":"11","first-page":"31","unstructured":null,"article-title":"The performance of the SRMR, RMSEA, CFI, and TLI: an examination of sample size, path size, and degrees of freedom.","journal-title":"J Appl Quant Methods","doi-asserted-by":null},{"DOI":"10.1080/00273171.2020.1868965","key":"doi250063r30","year":"2022","issue":"2-3","author":"Shi","volume":"57","first-page":"179","unstructured":null,"article-title":"Evaluating SEM model fit with small degrees of freedom.","journal-title":"Multivariate Behav Res","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11136-021-02925-y","key":"doi250063r31","year":"2021","issue":"10","author":"Terwee","volume":"30","first-page":"2729","unstructured":null,"article-title":"Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures.","journal-title":"Qual Life Res","doi-asserted-by":"publisher"},{"DOI":"10.1111/jdv.20321","key":"doi250063r33","year":"2025","issue":"3","author":"Vyas","volume":"39","first-page":"631","unstructured":null,"article-title":"The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: a systematic review.","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2019.09.008","key":"doi250063r34","year":"2023","issue":"1","author":"Perez-Chada","volume":"88","first-page":"86","unstructured":null,"article-title":"Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1093/bjd/ljaf127","key":"doi250063r35","year":"2025","issue":"2","author":"Nock","volume":"193","first-page":"267","unstructured":null,"article-title":"Measurement properties of the Comprehensive Quality-of-Life Measure for Acne (CompAQ): a cohort study at three international sites.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.12.017","key":"doi250063r36","year":"2024","issue":"5","author":"Reynolds","volume":"90","first-page":"1006.e1","unstructured":null,"article-title":"Guidelines of care for the management of acne vulgaris.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.08.102","key":"doi250063r37","year":"2024","issue":"2","author":"Davis","volume":"90","first-page":"e43","unstructured":null,"article-title":"Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.04.061","key":"doi250063r38","year":"2022","issue":"3","author":"Chatrath","volume":"87","first-page":"582","unstructured":null,"article-title":"Longitudinal course and predictors of depressive symptoms in atopic dermatitis.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.2165/00128071-200304120-00003","key":"doi250063r39","year":"2003","issue":"12","author":"Gupta","volume":"4","first-page":"833","unstructured":null,"article-title":"Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management.","journal-title":"Am J Clin Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.18514","key":"doi250063r40","year":"2020","issue":"3","author":"Gaufin","volume":"182","first-page":"786","unstructured":null,"article-title":"Practical screening for depression in dermatology: using technology to improve care.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.14031","key":"doi250063r41","year":"2015","issue":"6","author":"Silverberg","volume":"173","first-page":"1400","unstructured":null,"article-title":"Assessment of atopic dermatitis using self-report and caregiver report: a multicentre validation study.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1159/000136655","key":"doi250063r42","year":"2008","issue":"2","author":"Menon","volume":"217","first-page":"164","unstructured":null,"article-title":"Validity of subject self-report for acne.","journal-title":"Dermatology","doi-asserted-by":"publisher"},{"DOI":"10.1038/JID.2015.386","key":"doi250063r43","year":"2016","issue":"1","author":"Modalsli","volume":"136","first-page":"323","unstructured":null,"article-title":"Validity of self-reported psoriasis in a general population: the HUNT Study, Norway.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.anai.2018.07.040","key":"doi250063r44","year":"2018","issue":"6","author":"Silverberg","volume":"121","first-page":"729","unstructured":null,"article-title":"Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.","journal-title":"Ann Allergy Asthma Immunol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2024.5679","key":"doi250063r45","year":"2025","issue":"3","author":"Griffiths","volume":"161","first-page":"332","unstructured":null,"article-title":"Validation of the Acne Core Outcomes Research Network patient global assessment for acne.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/jdv.16562","key":"doi250063r46","year":"2021","issue":"1","author":"van Geel","volume":"35","first-page":"216","unstructured":null,"article-title":"Validation of a patient global assessment for extent, severity and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES).","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"publisher"},{"DOI":"10.1111/j.0022-202X.2005.23775.x","key":"doi250063r47","year":"2005","issue":"4","author":"Nijsten","volume":"125","first-page":"665","unstructured":null,"article-title":"The psychometric properties of the Psoriasis Disability Index in United States patients.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jclinepi.2007.03.012","key":"doi250063r48","year":"2008","issue":"2","author":"Revicki","volume":"61","first-page":"102","unstructured":null,"article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.","journal-title":"J Clin Epidemiol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s10209-018-0617-5","key":"doi250063r49","year":"2019","issue":"4","author":"Hargittai","volume":"18","first-page":"881","unstructured":null,"article-title":"From internet access to internet skills: digital inequality among older adults.","journal-title":"Univers Access Inf Soc","doi-asserted-by":"publisher"},{"DOI":"10.1111/jgs.12747","key":"doi250063r50","year":"2014","issue":"4","author":"Remillard","volume":"62","first-page":"696","unstructured":null,"article-title":"Systematic review of the use of online questionnaires of older adults.","journal-title":"J Am Geriatr Soc","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jval.2021.08.011","key":"doi250063r51","year":"2022","issue":"2","author":"Peipert","volume":"25","first-page":"161","unstructured":null,"article-title":"Do you recall?: results from a within-person recall study of the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0–Physical Function 8c.","journal-title":"Value Health","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi250063r9","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"HealthMeasures. PROMIS measures in Epic. Accessed June 28, 2024. https://www.healthmeasures.net/implement-healthmeasures/administration-platforms/epic","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r18","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Anxiety instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Anxiety_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r19","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Depression instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Depression_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r20","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Satisfaction With Social Roles and Activities instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/promis/manuals/PROMIS_Satisfaction_with_Participation_in_Social_Roles_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r21","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Social Isolation instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Social_Isolation_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r22","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Pain Intensity instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Pain_Intensity_Scoring_Manual.pdf","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r23","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Patient-Reported Outcomes Measurement Information System. A brief guide to the PROMIS Itch instruments. Accessed July 12, 2025. https://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Itch_Scoring_Manual.pdf.","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi250063r32","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"HealthMeasures. Meaningful change for PROMIS. Accessed October 19, 2025. https://www.healthmeasures.net/score-and-interpret/interpret-scores/promis/meaningful-change","article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Dermatology"],"reference-count":51,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2025,12,23]]},"references-count":51,"short-container-title":["JAMA Dermatol"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1001/jamadermatol.2025.5163","is_oa":true,"title":"Measurement Properties of PROMIS Measures Relevant to Chronic Skin Diseases","updated":"2025-12-27T00:44:22+00:00","published_date":"2025-12-23","best_oa_location":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12728729/","pmh_id":"oai:pubmedcentral.nih.gov:12728729","url_for_pdf":null,"url_for_landing_page":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12728729/"}}},"created_at":"2026-01-19T09:31:36.873Z","updated_at":"2026-01-21T12:05:26.220Z","tags":[{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"age_group","value":"adult (18-64)","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"condition","value":"Atopic Dermatitis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"condition","value":"Psoriasis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"level_of_evidence","value":"3","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"sample_size","value":"n=549","value_numeric":549},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"study_design","value":"Cohort Study","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"warning","value":"Design classified as a cohort study based on the abstract description.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"warning","value":"Diagnoses were self-reported via an online survey platform, which may limit generalizability to clinician-confirmed populations.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2025.5163","tag_type":"warning","value":"Only a 3-month follow-up was evaluated; longer-term responsiveness is not addressed.","value_numeric":null}],"summaries":{"what_studied":"Adults (≥18 years) in the US with self-reported chronic skin diseases completed PROMIS short forms (anxiety, depression, social satisfaction, social isolation) and single-item itch and pain at baseline and 3 months to test structural validity, internal consistency, construct validity, and responsiveness against dermatology measures.","key_result":"Across 549 participants, PROMIS short forms showed adequate structural validity (CFI/TLI >0.95; SRMR <0.08) and high internal consistency (Cronbach α >0.90), with sufficient construct validity (Pearson r ≥0.30 for similar constructs). Responsiveness by SRM: pain 0.41 and itch 0.32–0.44 (similar to Skindex-29 symptoms 0.47); social satisfaction −0.20 and isolation 0.27 (similar to Skindex-29 functioning 0.25); anxiety 0.11 and depression 0.16 (lower than Skindex-29 emotions 0.43).","practice_takeaway":"PROMIS pain, itch, and social measures tracked 3-month changes similarly to Skindex-29 domains, supporting their use in dermatology clinics; PROMIS anxiety and depression were less responsive than Skindex-29 emotions."}},{"doi":"10.1111/ijd.70101","pmid":"41195756","title":"International Expert Consensus on Knowledge Gaps in Care for Dermatologic Disorders in Skin of Color","journal_title":"International Journal of Dermatology","journal_issn":"0011-9059","published_at":"2025-11-06T00:00:00.000Z","url":"https://doi.org/10.1111/ijd.70101","source_score":4,"is_retracted":false,"is_open_access":false,"raw_metadata":{"ooir":{"day":"2025-11-11","doi":"10.1111/ijd.70101","days":"7","issn":"0011-9059","rank":"6","field":"Clinical Medicine","score":"4","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1111/ijd.70101","title":"International Expert Consensus on Knowledge Gaps in Care for Dermatologic Disorders in Skin of Color.","journal":"International journal of dermatology","methods":"","results":"","abstract":"$35","keywords":["SOC","acne keloid","alopecia","atopic dermatitis","healthcare disparities","knowledge gap","melasma","skin of color","skin pigmentation"],"pubmed_id":"41195756","conclusions":"","publication_date":"2025-11-06T00:00:00"},"crossref":{"DOI":"10.1111/ijd.70101","URL":"https://doi.org/10.1111/ijd.70101","ISSN":["0011-9059","1365-4632"],"link":[{"URL":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.70101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":null,"type":"journal-article","issue":null,"score":1,"title":["International Expert Consensus on Knowledge Gaps in Care for Dermatologic Disorders in Skin of Color"],"author":[{"given":"Henry W.","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Dermatology Henry Ford Health Detroit Michigan USA"}]},{"given":"Chengfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology Huashan Hospital, Fudan University Shanghai China"}]},{"given":"Marisa","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Dermatology Epsom & St Helier University Hospitals NHS Trust Sutton UK"}]},{"given":"Ncoza C.","family":"Dlova","sequence":"additional","affiliation":[{"name":"Nelson R. Mandela School of Medicine University of KwaZulu‐Natal Durban South Africa"}]},{"given":"Katleen","family":"Conceição","sequence":"additional","affiliation":[{"name":"Dermatology in Black Skin Federal Hospital, Bonsucesso Rio de Janeiro Brazil"}]},{"given":"Nina","family":"Jablonski","sequence":"additional","affiliation":[{"name":"Department of Anthropology The Pennsylvania State University University Park Pennsylvania USA"}]},{"given":"Neha","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Dermatology Madhya Pradesh Medical Science University Jabalpur Madhya Pradesh India"}]},{"given":"Janet","family":"Wangari‐Olivero","sequence":"additional","affiliation":[{"name":"L'Oreal Research and Innovation Clark New Jersey USA"}]},{"given":"Andrew","family":"Alexis","sequence":"additional","affiliation":[{"name":"Department of Dermatology Weill Cornell Medicine New York New York USA"}]}],"issued":{"date-parts":[[2025,11,6]]},"member":"311","prefix":"10.1111","source":"Crossref","volume":null,"archive":["Portico"],"created":{"date-time":"2025-11-06T11:54:07Z","timestamp":1762430047000,"date-parts":[[2025,11,6]]},"indexed":{"date-time":"2025-11-06T12:01:37Z","timestamp":1762430497941,"date-parts":[[2025,11,6]]},"license":[{"URL":"http://creativecommons.org/licenses/by-nc/4.0/","start":{"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000,"date-parts":[[2025,11,6]]},"delay-in-days":0,"content-version":"vor"}],"subject":[],"abstract":"$36","language":"en","relation":{},"resource":{"primary":{"URL":"https://onlinelibrary.wiley.com/doi/10.1111/ijd.70101"}},"subtitle":[],"assertion":[{"name":"received","group":{"name":"publication_history","label":"Publication History"},"label":"Received","order":0,"value":"2025-07-08"},{"name":"accepted","group":{"name":"publication_history","label":"Publication History"},"label":"Accepted","order":2,"value":"2025-10-02"},{"name":"published","group":{"name":"publication_history","label":"Publication History"},"label":"Published","order":3,"value":"2025-11-06"}],"deposited":{"date-time":"2025-11-06T11:54:12Z","timestamp":1762430052000,"date-parts":[[2025,11,6]]},"issn-type":[{"type":"print","value":"0011-9059"},{"type":"electronic","value":"1365-4632"}],"published":{"date-parts":[[2025,11,6]]},"publisher":"Wiley","reference":[{"DOI":"10.1111/ijd.70100","key":"e_1_2_11_2_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.03.001","key":"e_1_2_11_3_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2022.10.007","key":"e_1_2_11_4_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.03.053","key":"e_1_2_11_5_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ijwd.2021.04.001","key":"e_1_2_11_6_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2019.05.009","key":"e_1_2_11_7_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_8_1","year":"2005","issue":null,"author":"Taylor S. C.","volume":"76","first-page":"249","unstructured":null,"article-title":"Enhancing the Care and Treatment of Skin of Color, Part 1: The Broad Scope of Pigmentary Disorders","journal-title":"Cutis","doi-asserted-by":null},{"DOI":"10.1016/j.jaad.2021.11.009","key":"e_1_2_11_9_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_10_1","year":"2019","issue":null,"author":"Alexis A. F.","volume":"18","first-page":"616","unstructured":null,"article-title":"Myths and Knowledge Gaps in the Aesthetic Treatment of Patients With Skin of Color","journal-title":"Journal of Drugs in Dermatology","doi-asserted-by":null},{"DOI":"10.1111/bjd.13462","key":"e_1_2_11_11_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/j.1468‐3083.2010.03919.x","key":"e_1_2_11_12_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.14525","key":"e_1_2_11_13_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_14_1","year":"2022","issue":null,"author":"Pathmarajah P.","volume":"15","first-page":"43","unstructured":null,"article-title":"Acne Vulgaris in Skin of Color: A Systematic Review of the Effectiveness and Tolerability of Current Treatments","journal-title":"Journal of Clinical and Aesthetic Dermatology","doi-asserted-by":null},{"DOI":"10.1111/ijd.17189","key":"e_1_2_11_15_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.02.053","key":"e_1_2_11_16_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_17_1","year":"2024","issue":null,"author":"Alexis A.","volume":"17","first-page":"16","unstructured":null,"article-title":"Is Acne the Same Around the World?","journal-title":"Journal of Clinical and Aesthetic Dermatology","doi-asserted-by":null},{"DOI":"10.1111/1346‐8138.15048","key":"e_1_2_11_18_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257‐023‐00797‐1","key":"e_1_2_11_19_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.SF395747","key":"e_1_2_11_20_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s13555‐019‐00332‐3","key":"e_1_2_11_21_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.3390/jcm12144675","key":"e_1_2_11_22_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.aller.2012.03.001","key":"e_1_2_11_23_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s13555‐022‐00875‐y","key":"e_1_2_11_24_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1097/jw9.0000000000000014","key":"e_1_2_11_25_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.003","key":"e_1_2_11_26_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.12788/cutis.0887","key":"e_1_2_11_27_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1089/derm.2023.0051","key":"e_1_2_11_28_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/978‐3‐031‐54513‐9_5","key":"e_1_2_11_29_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.3390/jcm12072701","key":"e_1_2_11_30_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1093/ced/llad111","key":"e_1_2_11_31_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.66091","key":"e_1_2_11_32_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_33_1","year":"2023","issue":null,"author":"Alexis A. F.","volume":"22","first-page":"SF386361s386363","unstructured":null,"article-title":"An Algorithm for the Management of Atopic Dermatitis in People With Skin of Color","journal-title":"Journal of Drugs in Dermatology","doi-asserted-by":null},{"DOI":"10.1016/j.det.2023.02.002","key":"e_1_2_11_34_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_35_1","year":"2014","issue":null,"author":"Alexis A. F.","volume":"7","first-page":"16","unstructured":null,"article-title":"Psoriasis in Skin of Color: Epidemiology, Genetics, Clinical Presentation, and Treatment Nuances","journal-title":"Journal of Clinical and Aesthetic Dermatology","doi-asserted-by":null},{"DOI":"10.5070/d3247040909","key":"e_1_2_11_36_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.6910","key":"e_1_2_11_37_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1080/09546634.2024.2365820","key":"e_1_2_11_38_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s13555‐022‐00811‐0","key":"e_1_2_11_39_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/ijd.17236","key":"e_1_2_11_40_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.5070/d32010024262","key":"e_1_2_11_41_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2018.08.049","key":"e_1_2_11_42_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.4103/ijdvl.IJDVL_769_19","key":"e_1_2_11_43_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_44_1","year":"2019","issue":null,"author":"Cices A.","volume":"18","first-page":"608","unstructured":null,"article-title":"Patient‐Focused Solutions in Rosacea Management: Treatment Challenges in Special Patient Groups","journal-title":"Journal of Drugs in Dermatology","doi-asserted-by":null},{"DOI":"10.7573/dic.2021‐11‐1","key":"e_1_2_11_45_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_46_1","year":"2019","issue":null,"author":"Elgash M.","volume":"18","first-page":"24","unstructured":null,"article-title":"Seborrheic Dermatitis in Skin of Color: Clinical Considerations","journal-title":"Journal of Drugs in Dermatology","doi-asserted-by":null},{"DOI":"10.12688/f1000research.26083.1","key":"e_1_2_11_47_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.001","key":"e_1_2_11_48_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.5747","key":"e_1_2_11_49_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/ijd.16163","key":"e_1_2_11_50_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1177/12034754241269125","key":"e_1_2_11_51_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2024.10.073","key":"e_1_2_11_52_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/exd.14340","key":"e_1_2_11_53_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/ijd.15671","key":"e_1_2_11_54_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/exd.14341","key":"e_1_2_11_55_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s00403‐024‐02931‐3","key":"e_1_2_11_56_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1089/derm.2022.29011.abu","key":"e_1_2_11_57_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s11882‐024‐01148‐8","key":"e_1_2_11_58_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s00228‐020‐03005‐9","key":"e_1_2_11_59_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.009","key":"e_1_2_11_60_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1002/acr.24712","key":"e_1_2_11_61_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jdcr.2023.05.019","key":"e_1_2_11_62_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.006","key":"e_1_2_11_63_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.6557","key":"e_1_2_11_64_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.07.1045","key":"e_1_2_11_65_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/phpp.12783","key":"e_1_2_11_66_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.005","key":"e_1_2_11_67_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/jocd.14916","key":"e_1_2_11_68_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1080/09546634.2020.1793892","key":"e_1_2_11_69_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.4103/0019‐5154.190108","key":"e_1_2_11_70_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_71_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"“ILDS Warns Against the Misuse of Topical Corticosteroids and Calls for Global Action on Skin‐bleaching ”Updated Position Statement Advocates for Improved Patient Protection and Education 2025 https://www.ilds.org/news‐events/news/ILDS‐Warns‐Against‐Misuse‐Topical‐Corticosteroids/.","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.2471/blt.23.020623","key":"e_1_2_11_72_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.4103/Pigmentinternational.Pigmentinternational_19_21","key":"e_1_2_11_73_1","year":"2021","issue":null,"author":"Coondoo A.","volume":"8","first-page":"4","unstructured":null,"article-title":"The Unhealthy Obsession with Fairness and the Menace of Fairness Creams in India","journal-title":"Pigment International","doi-asserted-by":"crossref"},{"DOI":"10.1016/j.ijwd.2020.09.006","key":"e_1_2_11_74_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/ijd.17237","key":"e_1_2_11_75_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ijwd.2021.01.017","key":"e_1_2_11_76_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/ijd.16374","key":"e_1_2_11_77_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1097/dss.0000000000003440","key":"e_1_2_11_78_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.013","key":"e_1_2_11_79_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257‐021‐00662‐z","key":"e_1_2_11_80_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_81_1","year":"2021","issue":null,"author":"Jackson B. A.","volume":null,"first-page":"257","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"e_1_2_11_82_1","year":"2022","issue":null,"author":"Shao K.","volume":"15","first-page":"16","unstructured":null,"article-title":"Racial and Ethnic Healthcare Disparities in Skin Cancer in the United States: A Review of Existing Inequities, Contributing Factors, and Potential Solutions","journal-title":"Journal of Clinical and Aesthetic Dermatology","doi-asserted-by":null},{"DOI":"10.1016/j.jaad.2021.12.062","key":"e_1_2_11_83_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jdin.2021.05.006","key":"e_1_2_11_84_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.04.057","key":"e_1_2_11_85_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.04.056","key":"e_1_2_11_86_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1155/2022/5014610","key":"e_1_2_11_87_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.5826/dpc.1304S1a308S","key":"e_1_2_11_88_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ijwd.2020.11.009","key":"e_1_2_11_89_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.5826/dpc.1304S1a311S","key":"e_1_2_11_90_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257‐017‐0332‐7","key":"e_1_2_11_91_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/phpp.12749","key":"e_1_2_11_92_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_93_1","year":"2010","issue":null,"author":"Krige J.","volume":"48","first-page":"74","unstructured":null,"article-title":"Melanoma in Black South Africans","journal-title":"South African Journal of Surgery","doi-asserted-by":null},{"DOI":"10.1097/dss.0000000000000285","key":"e_1_2_11_94_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.6469","key":"e_1_2_11_95_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2021.09.002","key":"e_1_2_11_96_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.014","key":"e_1_2_11_97_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.3928/19382359‐20240205‐07","key":"e_1_2_11_98_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.pedhc.2019.04.019","key":"e_1_2_11_99_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2017.06.159","key":"e_1_2_11_100_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2016.02.1162","key":"e_1_2_11_101_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/ijd.17184","key":"e_1_2_11_102_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/exd.13664","key":"e_1_2_11_103_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.2147/ccid.s247390","key":"e_1_2_11_104_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.4103/0974‐7753.58556","key":"e_1_2_11_105_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.5826/dpc.1304S1a310S","key":"e_1_2_11_106_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.12788/cutis.0750","key":"e_1_2_11_107_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1159/000528518","key":"e_1_2_11_108_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.6972","key":"e_1_2_11_109_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.det.2023.02.008","key":"e_1_2_11_110_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.14659","key":"e_1_2_11_111_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s43630‐022‐00314‐z","key":"e_1_2_11_112_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257‐021‐00670‐z","key":"e_1_2_11_113_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2024.02.065","key":"e_1_2_11_114_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/ijd.16954","key":"e_1_2_11_115_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.8250","key":"e_1_2_11_116_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.36849/jdd.2020.5032","key":"e_1_2_11_117_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2021.12.019","key":"e_1_2_11_118_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2021.12.024","key":"e_1_2_11_119_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2021.12.023","key":"e_1_2_11_120_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2022.0263","key":"e_1_2_11_121_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2020.4616","key":"e_1_2_11_122_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1155/2018/1965674","key":"e_1_2_11_123_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_124_1","year":"2020","issue":null,"author":"Huang C.","volume":null,"first-page":"29","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":"10.1111/jocd.15739","key":"e_1_2_11_125_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1097/dss.0000000000002813","key":"e_1_2_11_126_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1177/1203475420957633","key":"e_1_2_11_127_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1080/14764172.2024.2376701","key":"e_1_2_11_128_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s00403‐023‐02640‐3","key":"e_1_2_11_129_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1097/dss.0000000000003733","key":"e_1_2_11_130_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_131_1","year":"2024","issue":null,"author":"Sanyal R. D.","volume":"17","first-page":"22","unstructured":null,"article-title":"Energy‐Based Devices for the Treatment of Facial Skin Conditions in Skin of Color","journal-title":"Journal of Clinical and Aesthetic Dermatology","doi-asserted-by":null},{"DOI":"10.3390/jcm13072116","key":"e_1_2_11_132_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s10103‐023‐03744‐y","key":"e_1_2_11_133_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.3390/cosmetics11030089","key":"e_1_2_11_134_1","year":"2024","issue":null,"author":"Lu P.‐H.","volume":"11","first-page":null,"unstructured":null,"article-title":"Comparing a Low‐Fluence Picosecond 1064 nm Nd:YAG Laser with a 532 nm Nd:YAG Laser for the Treatment of Pigmented Lesions in Chinese Patients: A Retrospective Analysis","journal-title":"Cosmetics","doi-asserted-by":"crossref"},{"DOI":"10.1097/dss.0000000000004393","key":"e_1_2_11_135_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s10103‐022‐03566‐4","key":"e_1_2_11_136_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s00403‐023‐02794‐0","key":"e_1_2_11_137_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/jocd.16432","key":"e_1_2_11_138_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s10103‐023‐03810‐5","key":"e_1_2_11_139_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.2147/ccid.S470997","key":"e_1_2_11_140_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/978-3-030-44766-3_43","key":"e_1_2_11_141_1","year":"2020","issue":null,"author":"Tchero H.","volume":null,"first-page":"371","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.36849/jdd.7253","key":"e_1_2_11_142_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1007/s13555‐020‐00427‐2","key":"e_1_2_11_143_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1186/s41038‐019‐0175‐y","key":"e_1_2_11_144_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1002/lsm.23201","key":"e_1_2_11_145_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.4103/jcas.Jcas_154_19","key":"e_1_2_11_146_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/jocd.15572","key":"e_1_2_11_147_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1002/lsm.23484","key":"e_1_2_11_148_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2023.10.074","key":"e_1_2_11_149_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_150_1","year":"2017","issue":null,"author":"Cheng J.","volume":null,"first-page":"437","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"e_1_2_11_151_1","year":"2023","issue":null,"author":"Khunger N.","volume":null,"first-page":"171","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"e_1_2_11_152_1","year":"2023","issue":null,"author":"Desai M.","volume":"16","first-page":"37","unstructured":null,"article-title":"Cosmetic Procedures in Patients with Skin of Color: Clinical Pearls and Pitfalls","journal-title":"Journal of Clinical and Aesthetic Dermatology","doi-asserted-by":null},{"DOI":"10.1097/psn.0000000000000483","key":"e_1_2_11_153_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.2147/ccid.S450081","key":"e_1_2_11_154_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/B978-0-323-83144-4.00024-1","key":"e_1_2_11_155_1","year":"2025","issue":null,"author":"Grimes P. E.","volume":null,"first-page":"169","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.1016/j.clindermatol.2024.06.024","key":"e_1_2_11_156_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2021.03.116","key":"e_1_2_11_157_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/jocd.16297","key":"e_1_2_11_158_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":null,"key":"e_1_2_11_159_1","year":"2021","issue":null,"author":"Corduff N.","volume":"14","first-page":"E76","unstructured":null,"article-title":"Pan‐Asian Consensus on Calcium Hydroxyapatite for Skin Biostimulation, Contouring, and Combination Treatments","journal-title":"Journal of Clinical and Aesthetic Dermatology","doi-asserted-by":null},{"DOI":null,"key":"e_1_2_11_160_1","year":"2022","issue":null,"author":"Gold M.","volume":"21","first-page":"Sf3509903","unstructured":null,"article-title":"Supplement Individual Article: Algorithm for Pre‐/Post‐Procedure Measures in Racial/Ethnic Populations Treated With Facial Lasers, Nonenergy Devices, or Injectables","journal-title":"Journal of Drugs in Dermatology","doi-asserted-by":null},{"DOI":"10.36849/jdd.8092","key":"e_1_2_11_161_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"},{"DOI":"10.1111/jocd.16712","key":"e_1_2_11_162_1","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"publisher"}],"short-title":[],"update-policy":"https://doi.org/10.1002/crossmark_policy","alternative-id":["10.1111/ijd.70101"],"article-number":"ijd.70101","content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"original-title":[],"container-title":["International Journal of Dermatology"],"reference-count":161,"published-online":{"date-time":null,"timestamp":null,"date-parts":[[2025,11,6]]},"references-count":161,"short-container-title":["Int J Dermatology"],"is-referenced-by-count":0},"unpaywall":{"doi":"10.1111/ijd.70101","is_oa":false,"title":"International Expert Consensus on Knowledge Gaps in Care for Dermatologic Disorders in Skin of Color","updated":"2025-11-07T00:31:01+00:00","published_date":"2025-11-06","best_oa_location":null}},"created_at":"2025-11-18T07:49:07.762Z","updated_at":"2025-11-18T07:49:07.762Z","tags":[{"paper_doi":"10.1111/ijd.70101","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"condition","value":"Atopic Dermatitis","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"condition","value":"Hair Disorders","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"condition","value":"Melasma","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"condition","value":"Post-Inflammatory Hyperpigmentation","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"condition","value":"Psoriasis","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"condition","value":"Rosacea","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"condition","value":"Skin Cancer","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"level_of_evidence","value":"7","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"study_design","value":"Expert Consensus","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"warning","value":"Findings are based on a PubMed title/abstract search from 2019–2024, which may have missed relevant studies outside these terms.","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"warning","value":"No quantitative outcomes or effect sizes are provided.","value_numeric":null},{"paper_doi":"10.1111/ijd.70101","tag_type":"warning","value":"Study design classification inferred from the abstract; formal consensus methodology is not detailed.","value_numeric":null}],"summaries":{"what_studied":"An international panel reviewed PubMed articles with “skin of color” or “skin of colour” in the title/abstract from September 2019 to September 2024 to map research and clinical care gaps for skin of color across skin diseases, hair disorders, photoprotection, and aesthetic procedures.","key_result":"The panel highlighted consistent gaps: inflammatory diseases in skin of color need tailored diagnosis and treatment due to unique presentations and challenges detecting erythema and managing post‑inflammatory hyperpigmentation; pigmentary disorders strongly affect quality of life and unsafe skin bleaching with high‑potency corticosteroids poses serious risks; skin cancer often presents late with poorer outcomes; and photoprotection and aesthetic care lack inclusive evidence and guidance.","limitations":"The search was limited to PubMed and to papers with “skin of color/colour” in the title or abstract, which may miss relevant studies. No quantitative outcomes or effect estimates are reported, and formal consensus methods are not described.","practice_takeaway":"In patients with skin of color, expect different visual cues and prioritize detection of erythema and post‑inflammatory hyperpigmentation; tailor treatment and counsel on photoprotection and the dangers of unregulated bleaching agents. Be vigilant for late‑presenting skin cancers and proceed cautiously with aesthetic procedures given sparse, non‑inclusive trial data."}},{"doi":"10.1001/jamadermatol.2024.0594","pmid":"38656377","title":"Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders","journal_title":"JAMA Dermatology","journal_issn":"2168-6068","published_at":"2024-04-24T00:00:00.000Z","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11044010","source_score":89,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2024-05-05","doi":"10.1001/jamadermatol.2024.0594","days":"30","issn":"2168-6068","rank":"5","field":"Clinical Medicine","score":"89","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1001/jamadermatol.2024.0594","title":"Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders.","journal":"JAMA dermatology","methods":"","results":"$37","abstract":"$38","keywords":[],"pubmed_id":"38656377","conclusions":"","publication_date":"2024-04-24T00:00:00"},"crossref":{"DOI":"10.1001/jamadermatol.2024.0594","URL":"https://doi.org/10.1001/jamadermatol.2024.0594","ISSN":["2168-6068"],"link":[{"URL":"https://jamanetwork.com/journals/jamadermatology/articlepdf/2817886/jamadermatology_paller_2024_oi_240010_1717692698.49509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"621","type":"journal-article","issue":"6","score":1,"title":["Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders"],"author":[{"given":"Amy S.","family":"Paller","sequence":"first","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"},{"name":"Department of Pediatrics, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois"}]},{"given":"Stephanie M.","family":"Rangel","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}]},{"given":"Sarah L.","family":"Chamlin","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"},{"name":"Department of Pediatrics, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois"}]},{"given":"Aleena","family":"Hajek","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}]},{"given":"Sheshanna","family":"Phan","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}]},{"given":"Marcia","family":"Hogeling","sequence":"additional","affiliation":[{"name":"Department of Medicine/Dermatology, University of California, Los Angeles"}]},{"given":"Leslie","family":"Castelo-Soccio","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania"}]},{"given":"Irene","family":"Lara-Corrales","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, The Hospital for Sick Children, Toronto, Ontario, Canada"}]},{"given":"Lisa","family":"Arkin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, University of Wisconsin School of Medicine and Public Health, Madison"}]},{"given":"Leslie P.","family":"Lawley","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University, Atlanta, Georgia"}]},{"given":"Tracy","family":"Funk","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Oregon Health & Science University, Portland, Oregon"}]},{"given":"Fabiana","family":"Castro Porto Silva Lopes","sequence":"additional","affiliation":[{"name":"Department of Medicine/Dermatology, Dell Medical School, University of Texas at Austin"}]},{"given":"Richard J.","family":"Antaya","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale University, New Haven, Connecticut"}]},{"given":"Michele L.","family":"Ramien","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Alberta Children’s Hospital, Calgary, Alberta, Canada"}]},{"given":"Karina L.","family":"Vivar","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"},{"name":"Department of Pediatrics, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois"}]},{"given":"Joyce","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University School of Medicine, Stanford, California"}]},{"given":"Carrie C.","family":"Coughlin","sequence":"additional","affiliation":[{"name":"Department of Medicine/Dermatology, Washington University School of Medicine in St Louis, St Louis, Missouri"}]},{"given":"Wingfield","family":"Rehmus","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada"}]},{"given":"Deepti","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Seattle Children’s Hospital, University of Washington School of Medicine, Seattle"}]},{"given":"Lionel","family":"Bercovitch","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Hasbro Children’s Hospital, Brown University, Providence, Rhode Island"}]},{"given":"Sarah L.","family":"Stein","sequence":"additional","affiliation":[{"name":"Departments of Medicine/Dermatology and Pediatrics, University of Chicago, Chicago, Illinois"}]},{"given":"Christina","family":"Boull","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Minnesota, Minneapolis"}]},{"given":"Wynnis L.","family":"Tom","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Rady’s Children’s Hospital, University of California, San Diego"}]},{"given":"Marilyn G.","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts"}]},{"given":"Raegan","family":"Hunt","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Texas Children’s Hospital, Baylor College of Medicine, Houston"}]},{"given":"Minnelly","family":"Luu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Children’s Hospital Los Angeles, Los Angeles"}]},{"given":"Kristen E.","family":"Holland","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, Children’s Wisconsin, Medical College of Wisconsin, Milwaukee"}]},{"given":"Jennifer J.","family":"Schoch","sequence":"additional","affiliation":[{"name":"Department of Pediatric Dermatology, University of Florida, Gainesville"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}]},{"given":"Jin-Shei","family":"Lai","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}]},{"given":"James W.","family":"Griffith","sequence":"additional","affiliation":[{"name":"Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}]},{"given":null,"family":null,"sequence":"additional","affiliation":[]}],"issued":{"date-parts":[[2024,6,1]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":"160","created":{"date-time":"2024-04-24T15:33:38Z","timestamp":1713972818000,"date-parts":[[2024,4,24]]},"indexed":{"date-time":"2025-09-17T16:47:44Z","timestamp":1758127664242,"date-parts":[[2025,9,17]]},"subject":[],"abstract":"$39","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamadermatology/fullarticle/2817886"}},"subtitle":[],"deposited":{"date-time":"2024-06-19T15:00:50Z","timestamp":1718809250000,"date-parts":[[2024,6,19]]},"issn-type":[{"type":"print","value":"2168-6068"}],"published":{"date-parts":[[2024,6,1]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1038/jid.2013.446","key":"doi240010r1","year":"2014","issue":"6","author":"Hay","volume":"134","first-page":"1527","unstructured":null,"article-title":"The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.","journal-title":"J Invest Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/S0140-6736(20)30925-9","key":"doi240010r2","year":"2020","issue":"10258","author":"GBD 2019 Diseases and Injuries Collaborators","volume":"396","first-page":"1204","unstructured":null,"article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","journal-title":"Lancet","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.bodyim.2016.08.004","key":"doi240010r3","year":"2016","issue":null,"author":"Lakuta","volume":"19","first-page":"126","unstructured":null,"article-title":"The relationship between psoriasis and depression: a multiple mediation model.","journal-title":"Body Image","doi-asserted-by":"publisher"},{"DOI":"10.1097/MOP.0000000000000792","key":"doi240010r4","year":"2019","issue":"4","author":"Wu","volume":"31","first-page":"509","unstructured":null,"article-title":"The stigma of skin disease.","journal-title":"Curr Opin Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1542/peds.2004-0374","key":"doi240010r5","year":"2004","issue":"3","author":"Chamlin","volume":"114","first-page":"607","unstructured":null,"article-title":"Effects of atopic dermatitis on young American children and their families.","journal-title":"Pediatrics","doi-asserted-by":"publisher"},{"DOI":"10.1111/jdv.v36.4","key":"doi240010r6","year":"2022","issue":"4","author":"Luck-Sikorski","volume":"36","first-page":"499","unstructured":null,"article-title":"Assessment of stigma related to visible skin diseases: a systematic review and evaluation of patient-reported outcome measures.","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"publisher"},{"DOI":"10.1186/1477-7525-3-70","key":"doi240010r7","year":"2005","issue":null,"author":"Baars","volume":"3","first-page":"70","unstructured":null,"article-title":"The European DISABKIDS project: development of seven condition-specific modules to measure health related quality of life in children and adolescents.","journal-title":"Health Qual Life Outcomes","doi-asserted-by":"publisher"},{"DOI":"10.1007/s11136-023-03574-z","key":"doi240010r8","year":"2024","issue":"3","author":"Lai","volume":"33","first-page":"865","unstructured":null,"article-title":"Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks.","journal-title":"Qual Life Res","doi-asserted-by":"publisher"},{"DOI":"10.1001/archdermatol.2010.161","key":"doi240010r9","year":"2010","issue":"8","author":"Smidt","volume":"146","first-page":"865","unstructured":null,"article-title":"Development and validation of Skindex-Teen, a quality-of-life instrument for adolescents with skin disease.","journal-title":"Arch Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1177/1545968311412054","key":"doi240010r11","year":"2012","issue":"1","author":"Lai","volume":"26","first-page":"36","unstructured":null,"article-title":"Quality-of-life measures in children with neurological conditions: pediatric Neuro-QOL.","journal-title":"Neurorehabil Neural Repair","doi-asserted-by":"publisher"},{"DOI":"10.18637/jss.v067.i01","key":"doi240010r18","year":"2015","issue":"1","author":"Bates","volume":"67","first-page":"1","unstructured":null,"article-title":"Fitting linear mixed-effects models using lme4.","journal-title":"J Stat Softw","doi-asserted-by":"publisher"},{"DOI":"10.1542/peds.2022-061049","key":"doi240010r19","year":"2023","issue":"5","author":"Cotton","volume":"151","first-page":null,"unstructured":null,"article-title":"Hidradenitis suppurativa in pediatric patients.","journal-title":"Pediatrics","doi-asserted-by":"publisher"},{"DOI":"10.1111/jdv.v36.7","key":"doi240010r20","year":"2022","issue":"7","author":"Butt","volume":"36","first-page":"1118","unstructured":null,"article-title":"Internalized skin bias: validation study to explore the impact of the internalization of social stigma on those with hidradenitis suppurativa.","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"publisher"},{"DOI":"10.1159/000529194","key":"doi240010r21","year":"2023","issue":"3","author":"Bilgic","volume":"239","first-page":"445","unstructured":null,"article-title":"Internalized stigma in hidradenitis suppurativa: a multicenter cross-sectional study.","journal-title":"Dermatology","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.socscimed.2019.112749","key":"doi240010r22","year":"2020","issue":null,"author":"Hartog","volume":"246","first-page":null,"unstructured":null,"article-title":"Stigma reduction interventions for children and adolescents in low- and middle-income countries: systematic review of intervention strategies.","journal-title":"Soc Sci Med","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi240010r23","year":"2018","issue":"3","author":"Stephens","volume":"97","first-page":"187","unstructured":null,"article-title":"Childhood bullying: implications for physicians.","journal-title":"Am Fam Physician","doi-asserted-by":null},{"DOI":"10.1016/j.dr.2018.02.001","key":"doi240010r24","year":"2018","issue":null,"author":"Earnshaw","volume":"48","first-page":"178","unstructured":null,"article-title":"Stigma-based bullying interventions: a systematic review.","journal-title":"Dev Rev","doi-asserted-by":"publisher"},{"DOI":"10.1016/S0140-6736(15)00298-6","key":"doi240010r25","year":"2016","issue":"10023","author":"Thornicroft","volume":"387","first-page":"1123","unstructured":null,"article-title":"Evidence for effective interventions to reduce mental-health–related stigma and discrimination.","journal-title":"Lancet","doi-asserted-by":"publisher"},{"DOI":"10.1186/1753-2000-2-18","key":"doi240010r26","year":"2008","issue":"1","author":"Schachter","volume":"2","first-page":"18","unstructured":null,"article-title":"Effects of school-based interventions on mental health stigmatization: a systematic review.","journal-title":"Child Adolesc Psychiatry Ment Health","doi-asserted-by":"publisher"},{"DOI":"10.1097/NMD.0b013e31829480df","key":"doi240010r27","year":"2013","issue":"6","author":"Yamaguchi","volume":"201","first-page":"490","unstructured":null,"article-title":"Effects of short-term interventions to reduce mental health-related stigma in university or college students: a systematic review.","journal-title":"J Nerv Ment Dis","doi-asserted-by":"publisher"},{"DOI":"10.1186/s12887-021-02647-7","key":"doi240010r28","year":"2021","issue":"1","author":"Konradi","volume":"21","first-page":"173","unstructured":null,"article-title":"Stigma and psychological distress among pediatric participants in the FD/MAS Alliance Patient Registry.","journal-title":"BMC Pediatr","doi-asserted-by":"publisher"},{"DOI":"10.1080/09540121.2018.1527008","key":"doi240010r29","year":"2018","issue":"sup4","author":"Dow","volume":"30","first-page":"12","unstructured":null,"article-title":"Building resilience: a mental health intervention for Tanzanian youth living with HIV.","journal-title":"AIDS Care","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi240010r12","year":"2022","issue":null,"author":"Phan","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi240010r13","year":null,"issue":null,"author":"Wickham","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi240010r14","year":"1988","issue":null,"author":"Cohen","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi240010r10","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"HealthMeasures. Accessed March 20, 2024. https://www.healthmeasures.net/search-view-measures","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi240010r15","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Brueckl? M, Heuer? F. irrNA: Coefficients of interrater reliability–generalized for randomly incomplete datasets. R package version 0.2.3. 2022. Accessed September 3, 2023. https://CRAN.R-project.org/package=irrNA","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi240010r16","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Torchiano? M. effsize: Efficient effect size computation. R package version 0.8.1. 2020. Accessed September 3, 2023.? https://CRAN.R-project.org/package=effsize","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi240010r17","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"HealthMeasures. Accessed March 5, 2024. https://www.assessmentcenter.net/ac_scoringservice","article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Dermatology"],"published-print":{"date-parts":[[2024,6,1]]},"reference-count":29,"published-online":null,"references-count":29,"short-container-title":["JAMA Dermatol"],"is-referenced-by-count":26},"unpaywall":{"doi":"10.1001/jamadermatol.2024.0594","is_oa":true,"title":"Stigmatization and Mental Health Impact of Chronic Pediatric Skin Disorders","updated":"2025-07-30T00:59:52+00:00","published_date":"2024-04-24","best_oa_location":{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11044010","pmh_id":"oai:pubmedcentral.nih.gov:11044010","url_for_pdf":null,"url_for_landing_page":"https://www.ncbi.nlm.nih.gov/pmc/articles/11044010"}}},"created_at":"2025-09-20T07:59:12.576Z","updated_at":"2025-09-20T08:40:34.801Z","tags":[{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"age_group","value":"pediatric","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"condition","value":"Alopecia Areata","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"condition","value":"Atopic Dermatitis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"condition","value":"Hidradenitis Suppurativa","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"condition","value":"Hyperhidrosis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"condition","value":"Psoriasis","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"condition","value":"Vitiligo","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"level_of_evidence","value":"5","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"sample_size","value":"n=1671","value_numeric":1671},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"study_design","value":"Cross-Sectional Study","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"warning","value":"Comparator details for “children with a range of chronic diseases” are not described in the excerpt.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"warning","value":"Effect size signs in tables depend on group ordering; interpret direction using the table notes.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0594","tag_type":"warning","value":"Some diagnostic subgroups have very small sample sizes, so condition-specific estimates may be unstable.","value_numeric":null}],"summaries":{"what_studied":"Cross-sectional, single-visit study at 32 pediatric dermatology centers in the US and Canada (2018–2021) of 1671 children aged 8–17 with chronic skin disease and a parent. Stigma (PROMIS Stigma‑Skin) was examined by physician/child/proxy-rated visibility and severity, and its associations with quality of life (Skindex‑Teen), depression, anxiety, and peer relationships.","key_result":"Only 27.0% had minimal/no stigma (T<40) and 43.8% had at least moderate stigma (T≥45); stigma differed by visibility and severity and correlated with lower QOL (ρ=0.73), higher depression (ρ=0.61), higher anxiety (ρ=0.54), and poorer peer relations (ρ=−0.49). Bullying was reported by 29.4% of parents and was linked to higher stigma (Cohen d≈0.79), girls reported more stigma than boys (d=0.26), and stigma strongly predicted worse Skindex‑Teen total (estimate 1.05; 95% CI, 0.96–1.13).","limitations":"Cross-sectional, single-visit design limits causal inference. Conducted in specialty pediatric dermatology centers with small samples for some diagnoses (e.g., hyperhidrosis n=18; hidradenitis suppurativa n=22), which may affect generalizability and subgroup estimates.","practice_takeaway":"Do not rely solely on physician-rated severity or visibility to gauge impact. Routinely identify stigmatization and bullying and track change with validated tools to guide medical and psychosocial care."}},{"doi":"10.1001/jamadermatol.2024.0203","pmid":"38568616","title":"Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne Treatment","journal_title":"JAMA Dermatology","journal_issn":"2168-6068","published_at":"2024-04-03T00:00:00.000Z","url":"https://doi.org/10.1001/jamadermatol.2024.0203","source_score":65,"is_retracted":false,"is_open_access":false,"raw_metadata":{"ooir":{"day":"2024-05-19","doi":"10.1001/jamadermatol.2024.0203","days":"30","issn":"2168-6068","rank":"5","field":"Clinical Medicine","score":"65","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1001/jamadermatol.2024.0203","title":"Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne Treatment.","journal":"JAMA dermatology","methods":"","results":"Among 30 participants (14 [47%] males and 16 [53%] females) who completed the study requirements and were included in the analysis, knowledge of antibiotic guideline recommendations was high and antibiotic stewardship was believed to be a professional responsibility. Five salient themes were to be affecting long-term antibiotic prescriptions: perceived lack of evidence to justify change in dermatologic practice, difficulty navigating patient demands and satisfaction, discomfort with discussing contraception, iPLEDGE-related barriers, and the absence of an effective system to measure progress on antibiotic stewardship.","abstract":"$3a","keywords":[],"pubmed_id":"38568616","conclusions":"","publication_date":"2024-04-03T00:00:00"},"crossref":{"DOI":"10.1001/jamadermatol.2024.0203","URL":"https://doi.org/10.1001/jamadermatol.2024.0203","ISSN":["2168-6068"],"link":[{"URL":"https://jamanetwork.com/journals/jamadermatology/articlepdf/2817136/jamadermatology_festok_2024_oi_240005_1715718006.59577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"535","type":"journal-article","issue":"5","score":1,"title":["Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne Treatment"],"author":[{"given":"Ronnie A.","family":"Festok","sequence":"first","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Avni S.","family":"Ahuja","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Jared Y.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Lena","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Jason","family":"Barron","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Katherine","family":"Case","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Elaine","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Suephy C.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University School of Medicine, Durham, North Carolina"},{"name":"Division of Dermatology, Durham VA Medical Center, Durham, North Carolina"}]},{"given":"Jonathan","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Robert A.","family":"Swerlick","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Cam","family":"Escoffery","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Howa","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Associate Editor, JAMA Dermatology"}]}],"issued":{"date-parts":[[2024,5,1]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":"160","created":{"date-time":"2024-04-03T15:00:46Z","timestamp":1712156446000,"date-parts":[[2024,4,3]]},"indexed":{"date-time":"2025-07-26T09:00:41Z","timestamp":1753520441441,"date-parts":[[2025,7,26]]},"subject":[],"abstract":"$3b","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamadermatology/fullarticle/2817136"}},"subtitle":[],"deposited":{"date-time":"2024-05-15T15:03:16Z","timestamp":1715785396000,"date-parts":[[2024,5,15]]},"issn-type":[{"type":"print","value":"2168-6068"}],"published":{"date-parts":[[2024,5,1]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1016/j.jaad.2015.11.025","key":"doi240005r1","year":"2016","issue":"4","author":"Delost","volume":"74","first-page":"673","unstructured":null,"article-title":"Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.3399/BJGPO.2020.0181","key":"doi240005r2","year":"2021","issue":"3","author":"Bhate","volume":"5","first-page":null,"unstructured":null,"article-title":"Is there an association between long-term antibiotics for acne and subsequent infection sequelae and antimicrobial resistance? A systematic review.","journal-title":"BJGP Open","doi-asserted-by":"publisher"},{"DOI":"10.1001/archderm.139.4.467","key":"doi240005r3","year":"2003","issue":"4","author":"Levy","volume":"139","first-page":"467","unstructured":null,"article-title":"Effect of antibiotics on the oropharyngeal flora in patients with acne.","journal-title":"Arch Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/archderm.141.9.1132","key":"doi240005r4","year":"2005","issue":"9","author":"Margolis","volume":"141","first-page":"1132","unstructured":null,"article-title":"Antibiotic treatment of acne may be associated with upper respiratory tract infections.","journal-title":"Arch Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/archdermatol.2011.355","key":"doi240005r5","year":"2012","issue":"3","author":"Margolis","volume":"148","first-page":"326","unstructured":null,"article-title":"Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study.","journal-title":"Arch Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1038/ajg.2010.303","key":"doi240005r6","year":"2010","issue":"12","author":"Margolis","volume":"105","first-page":"2610","unstructured":null,"article-title":"Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.","journal-title":"Am J Gastroenterol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.291.7.827","key":"doi240005r7","year":"2004","issue":"7","author":"Velicer","volume":"291","first-page":"827","unstructured":null,"article-title":"Antibiotic use in relation to the risk of breast cancer.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.1007/s10620-015-3828-0","key":"doi240005r8","year":"2016","issue":"1","author":"Dik","volume":"61","first-page":"255","unstructured":null,"article-title":"Frequent use of antibiotics is associated with colorectal cancer risk: results of a nested case-control study.","journal-title":"Dig Dis Sci","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2015.12.037","key":"doi240005r9","year":"2016","issue":"5","author":"Zaenglein","volume":"74","first-page":"945","unstructured":null,"article-title":"Guidelines of care for the management of acne vulgaris.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2018.4944","key":"doi240005r10","year":"2019","issue":"3","author":"Barbieri","volume":"155","first-page":"290","unstructured":null,"article-title":"Trends in oral antibiotic prescription in dermatology, 2008 to 2016.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2014.02.031","key":"doi240005r11","year":"2014","issue":"1","author":"Lee","volume":"71","first-page":"70","unstructured":null,"article-title":"A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2015.01.048","key":"doi240005r12","year":"2015","issue":"5","author":"Straight","volume":"72","first-page":"822","unstructured":null,"article-title":"Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi240005r13","year":"2015","issue":"6","author":"Del Rosso","volume":"96","first-page":"376","unstructured":null,"article-title":"Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 3: oral therapies.","journal-title":"Cutis","doi-asserted-by":null},{"DOI":"10.15585/mmwr.rr6506a1","key":"doi240005r14","year":"2016","issue":"6","author":"Sanchez","volume":"65","first-page":"1","unstructured":null,"article-title":"Core elements of outpatient antibiotic stewardship.","journal-title":"MMWR Recomm Rep","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.03.069","key":"doi240005r15","year":"2022","issue":"5","author":"Chu","volume":"87","first-page":"e187","unstructured":null,"article-title":"Developing and implementing approaches to limit antimicrobial resistance.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1186/s13012-017-0605-9","key":"doi240005r16","year":"2017","issue":"1","author":"Atkins","volume":"12","first-page":"77","unstructured":null,"article-title":"A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems.","journal-title":"Implement Sci","doi-asserted-by":"publisher"},{"DOI":"10.1191/1478088706qp063oa","key":"doi240005r18","year":"2006","issue":"2","author":"Braun","volume":"3","first-page":"77","unstructured":null,"article-title":"Using thematic analysis in psychology.","journal-title":"Qual Res Psychol","doi-asserted-by":"publisher"},{"DOI":"10.1186/1748-5908-6-42","key":"doi240005r19","year":"2011","issue":"1","author":"Michie","volume":"6","first-page":"42","unstructured":null,"article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions.","journal-title":"Implement Sci","doi-asserted-by":"publisher"},{"DOI":"10.1177/1049732316665344","key":"doi240005r20","year":"2017","issue":"4","author":"Hennink","volume":"27","first-page":"591","unstructured":null,"article-title":"Code saturation versus meaning saturation: how many interviews are enough?","journal-title":"Qual Health Res","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.socscimed.2021.114523","key":"doi240005r21","year":"2022","issue":null,"author":"Hennink","volume":"292","first-page":null,"unstructured":null,"article-title":"Sample sizes for saturation in qualitative research: a systematic review of empirical tests.","journal-title":"Soc Sci Med","doi-asserted-by":"publisher"},{"DOI":"10.1093/cid/ciw217","key":"doi240005r23","year":"2016","issue":"10","author":"Barlam","volume":"62","first-page":"1197","unstructured":null,"article-title":"Executive summary: implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.","journal-title":"Clin Infect Dis","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi240005r24","year":"2016","issue":"4","author":"Del Rosso","volume":"9","first-page":"18","unstructured":null,"article-title":"Status report from the scientific panel on antibiotic use in dermatology of the American Acne and Rosacea Society: part 1, antibiotic prescribing patterns, sources of antibiotic exposure, antibiotic consumption and emergence of antibiotic resistance, impact of alterations in antibiotic prescribing, and clinical sequelae of antibiotic use.","journal-title":"J Clin Aesthet Dermatol","doi-asserted-by":null},{"DOI":"10.1111/jde.v47.8","key":"doi240005r25","year":"2020","issue":"8","author":"Nakase","volume":"47","first-page":"863","unstructured":null,"article-title":"Characterization of acne patients carrying clindamycin-resistant Cutibacterium acnes: a Japanese multicenter study.","journal-title":"J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.3389/fpubh.2022.787299","key":"doi240005r26","year":"2022","issue":null,"author":"Zhang","volume":"10","first-page":null,"unstructured":null,"article-title":"C. acnes qPCR-based Antibiotics Resistance Assay (ACQUIRE) reveals widespread macrolide resistance in acne patients and can eliminate macrolide misuse in acne treatment.","journal-title":"Front Public Health","doi-asserted-by":"publisher"},{"DOI":"10.1080/09546634.2016.1214234","key":"doi240005r27","year":"2017","issue":"2","author":"Austin","volume":"28","first-page":"145","unstructured":null,"article-title":"The extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin.","journal-title":"J Dermatolog Treat","doi-asserted-by":"publisher"},{"DOI":"10.1186/s12895-020-00108-9","key":"doi240005r28","year":"2020","issue":"1","author":"Alkhawaja","volume":"20","first-page":"17","unstructured":null,"article-title":"Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.","journal-title":"BMC Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1126/scitranslmed.abd8077","key":"doi240005r29","year":"2021","issue":"625","author":"Jo","volume":"13","first-page":null,"unstructured":null,"article-title":"Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics.","journal-title":"Sci Transl Med","doi-asserted-by":"publisher"},{"DOI":"10.1016/S0140-6736(04)17591-0","key":"doi240005r30","year":"2004","issue":"9452","author":"Ozolins","volume":"364","first-page":"2188","unstructured":null,"article-title":"Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.","journal-title":"Lancet","doi-asserted-by":"publisher"},{"DOI":"10.1136/bmj-2022-074349","key":"doi240005r31","year":"2023","issue":null,"author":"Santer","volume":"381","first-page":null,"unstructured":null,"article-title":"Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial.","journal-title":"BMJ","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi240005r32","year":"2019","issue":"6","author":"Del Rosso","volume":"12","first-page":"30","unstructured":null,"article-title":"Patient awareness of antimicrobial resistance and antibiotic use in acne vulgaris.","journal-title":"J Clin Aesthet Dermatol","doi-asserted-by":null},{"DOI":"10.1371/journal.pone.0076691","key":"doi240005r33","year":"2013","issue":"10","author":"Coenen","volume":"8","first-page":null,"unstructured":null,"article-title":"Are patient views about antibiotics related to clinician perceptions, management and outcome? a multi-country study in outpatients with acute cough.","journal-title":"PLoS One","doi-asserted-by":"publisher"},{"DOI":"10.1001/archpedi.160.9.945","key":"doi240005r34","year":"2006","issue":"9","author":"Mangione-Smith","volume":"160","first-page":"945","unstructured":null,"article-title":"Ruling out the need for antibiotics: are we sending the right message?","journal-title":"Arch Pediatr Adolesc Med","doi-asserted-by":"publisher"},{"DOI":"10.1093/ofid/ofaa417.021","key":"doi240005r35","year":"2020","issue":null,"author":"Hostetler","volume":"7","first-page":"S11","unstructured":null,"article-title":"Patient satisfaction remains unchanged following implementation of an antibiotic stewardship intervention in primary care.","journal-title":"Open Forum Infect Dis","doi-asserted-by":"publisher"},{"DOI":"10.1093/ofid/ofz360.1738","key":"doi240005r36","year":"2058","issue":null,"author":"Ray","volume":"6","first-page":"S693","unstructured":null,"article-title":"Patient satisfaction not impacted by antibiotic prescribing for viral upper respiratory infections.","journal-title":"Open Forum Infect Dis","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.amjmed.2010.05.009","key":"doi240005r37","year":"2010","issue":"10","author":"Steinkellner","volume":"123","first-page":"929","unstructured":null,"article-title":"Adherence to oral contraception in women on category X medications.","journal-title":"Am J Med","doi-asserted-by":"publisher"},{"DOI":"10.3109/09546634.2012.671908","key":"doi240005r38","year":"2012","issue":"4","author":"Landis","volume":"23","first-page":"272","unstructured":null,"article-title":"Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey.","journal-title":"J Dermatolog Treat","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2013.6862","key":"doi240005r39","year":"2014","issue":"4","author":"Werner","volume":"150","first-page":"366","unstructured":null,"article-title":"Women’s experiences with isotretinoin risk reduction counseling.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2014.4171","key":"doi240005r40","year":"2015","issue":"4","author":"Werner","volume":"151","first-page":"389","unstructured":null,"article-title":"Promoting safe use of isotretinoin by increasing contraceptive knowledge.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.2022.11489","key":"doi240005r41","year":"2022","issue":"17","author":"Rubin","volume":"328","first-page":"1671","unstructured":null,"article-title":"Threats to evidence-based care with teratogenic medications in states with abortion restrictions.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2022.07.026","key":"doi240005r42","year":"2022","issue":"5","author":"Yousif","volume":"87","first-page":"1225","unstructured":null,"article-title":"The Supreme Court abortion ban impact on dermatology.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jpag.2013.05.007","key":"doi240005r43","year":"2013","issue":"5","author":"Prevost","volume":"26","first-page":"290","unstructured":null,"article-title":"Isotretinoin: update on controversial issues.","journal-title":"J Pediatr Adolesc Gynecol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2019.3270","key":"doi240005r44","year":"2020","issue":"1","author":"Barbieri","volume":"156","first-page":"21","unstructured":null,"article-title":"Isotretinoin, patient safety, and patient-centered care-time to reform iPLEDGE.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2015.4763","key":"doi240005r45","year":"2016","issue":"3","author":"Mori","volume":"152","first-page":"338","unstructured":null,"article-title":"Personal burden of isotretinoin therapy and willingness to pay for electronic follow-up visits.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2020.02.022","key":"doi240005r46","year":"2020","issue":"1","author":"Barbieri","volume":"83","first-page":"104","unstructured":null,"article-title":"Simplifying contraception requirements for iPLEDGE: a decision analysis.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.12788/cutis","key":"doi240005r47","year":"2022","issue":"1","author":"Barbieri","volume":"110","first-page":"37","unstructured":null,"article-title":"Telemedicine and home pregnancy testing for iPLEDGE: a survey of clinician perspectives.","journal-title":"Cutis","doi-asserted-by":"publisher"},{"DOI":"10.1111/pde.v38.s2","key":"doi240005r48","year":"2021","issue":null,"author":"Shah","volume":"38","first-page":"183","unstructured":null,"article-title":"The future of iPLEDGE: We pledge for more inclusive access to isotretinoin.","journal-title":"Pediatr Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1017/ice.2014.41","key":"doi240005r49","year":"2015","issue":"2","author":"Drekonja","volume":"36","first-page":"142","unstructured":null,"article-title":"Antimicrobial stewardship in outpatient settings: a systematic review.","journal-title":"Infect Control Hosp Epidemiol","doi-asserted-by":"publisher"},{"DOI":"10.1503/cmaj.120568","key":"doi240005r50","year":"2012","issue":"13","author":"Légaré","volume":"184","first-page":"E726","unstructured":null,"article-title":"Training family physicians in shared decision-making to reduce the overuse of antibiotics in acute respiratory infections: a cluster randomized trial.","journal-title":"CMAJ","doi-asserted-by":"publisher"},{"DOI":"10.1111/hex.2011.14.issue-s1","key":"doi240005r51","year":"2011","issue":"Suppl 1","author":"Légaré","volume":"14","first-page":"96","unstructured":null,"article-title":"Training family physicians in shared decision making for the use of antibiotics for acute respiratory infections: a pilot clustered randomized controlled trial.","journal-title":"Health Expect","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.amjmed.2012.10.027","key":"doi240005r52","year":"2013","issue":"4","author":"Jenkins","volume":"126","first-page":"327","unstructured":null,"article-title":"Effects of clinical pathways for common outpatient infections on antibiotic prescribing.","journal-title":"Am J Med","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamainternmed.2013.14191","key":"doi240005r53","year":"2014","issue":"3","author":"Meeker","volume":"174","first-page":"425","unstructured":null,"article-title":"Nudging guideline-concordant antibiotic prescribing: a randomized clinical trial.","journal-title":"JAMA Intern Med","doi-asserted-by":"publisher"},{"DOI":"10.1001/jama.2013.6287","key":"doi240005r54","year":"2013","issue":"22","author":"Gerber","volume":"309","first-page":"2345","unstructured":null,"article-title":"Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi240005r55","year":"2018","issue":"5","author":"Dorobisz","volume":"101","first-page":"28","unstructured":null,"article-title":"Antimicrobial stewardship metrics: prospective audit with intervention and feedback.","journal-title":"R I Med J","doi-asserted-by":null},{"DOI":"10.1001/jama.2017.11152","key":"doi240005r56","year":"2017","issue":"14","author":"Linder","volume":"318","first-page":"1391","unstructured":null,"article-title":"Effects of behavioral interventions on inappropriate antibiotic prescribing in primary care 12 months after stopping interventions.","journal-title":"JAMA","doi-asserted-by":"publisher"},{"DOI":"10.3390/antibiotics11101306","key":"doi240005r58","year":"2022","issue":"10","author":"Sadeq","volume":"11","first-page":"1306","unstructured":null,"article-title":"Exploring antimicrobial stewardship influential interventions on improving antibiotic utilization in outpatient and inpatient settings: a systematic review and meta-analysis.","journal-title":"Antibiotics (Basel)","doi-asserted-by":"publisher"},{"DOI":"10.1186/1748-5908-8-81","key":"doi240005r59","year":"2013","issue":null,"author":"Taylor","volume":"8","first-page":"81","unstructured":null,"article-title":"Development and initial validation of the influences on patient safety behaviours questionnaire.","journal-title":"Implement Sci","doi-asserted-by":"publisher"},{"DOI":"10.1111/jdv.2016.30.issue-8","key":"doi240005r60","year":"2016","issue":"8","author":"Nast","volume":"30","first-page":"1261","unstructured":null,"article-title":"European evidence-based (S3) guideline for the treatment of acne - update 2016-short version.","journal-title":"J Eur Acad Dermatol Venereol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.adengl.2016.10.003","key":"doi240005r61","year":"2017","issue":"2","author":"López-Estebaranz","volume":"108","first-page":"120","unstructured":null,"article-title":"Consensus-based acne classification system and treatment algorithm for Spain.","journal-title":"Actas Dermosifiliogr","doi-asserted-by":"publisher"},{"DOI":"10.3399/bjgp21X717977","key":"doi240005r62","year":"2021","issue":"713","author":"Wilcock","volume":"71","first-page":"568","unstructured":null,"article-title":"New NICE guidance on acne vulgaris: implications for first-line management in primary care.","journal-title":"Br J Gen Pract","doi-asserted-by":"publisher"},{"DOI":"10.1111/jde.2018.45.issue-8","key":"doi240005r63","year":"2018","issue":"8","author":"Hayashi","volume":"45","first-page":"898","unstructured":null,"article-title":"Japanese Dermatological Association Guidelines: guidelines for the treatment of acne vulgaris, 2017.","journal-title":"J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1186/s13063-020-04432-w","key":"doi240005r64","year":"2020","issue":"1","author":"Poinas","volume":"21","first-page":"571","unstructured":null,"article-title":"FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.","journal-title":"Trials","doi-asserted-by":"publisher"},{"DOI":"10.36849/JDD.2020","key":"doi240005r65","year":"2020","issue":"12","author":"Barbieri","volume":"19","first-page":"1238","unstructured":null,"article-title":"Optimizing the trial design for a comparative effectiveness study of spironolactone versus oral antibiotics for women with acne: a Delphi consensus Panel.","journal-title":"J Drugs Dermatol","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi240005r66","year":"2018","issue":"6","author":"Barbieri","volume":"17","first-page":"632","unstructured":null,"article-title":"Frequency of treatment switching for spironolactone compared to oral tetracycline-class antibiotics for women with acne: a retrospective cohort study 2010-2016.","journal-title":"J Drugs Dermatol","doi-asserted-by":null},{"DOI":"10.1007/978-3-030-55829-1_15","key":"doi240005r57","year":"2021","issue":null,"author":"Stevens","volume":null,"first-page":"255","unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":"10.7573/dic.2022-8-2","key":"doi240005r17","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Drwiega? EN, Griffith? N, Herald? F, Badowski? ME. How to design and implement an outpatient antimicrobial stewardship programme. Drugs Context. 2023;12.","article-title":null,"journal-title":null,"doi-asserted-by":"crossref"},{"DOI":null,"key":"doi240005r22","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"iPLEDGE REMS. Accessed February 29, 2024. https://ipledgeprogram.com/#Main/PublicHome","article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,1]]}},"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Dermatology"],"published-print":{"date-parts":[[2024,5,1]]},"reference-count":66,"published-online":null,"references-count":66,"short-container-title":["JAMA Dermatol"],"is-referenced-by-count":3},"unpaywall":{"doi":"10.1001/jamadermatol.2024.0203","is_oa":false,"title":"Barriers and Facilitators Affecting Long-Term Antibiotic Prescriptions for Acne Treatment","updated":"2025-05-23T16:06:59+00:00","published_date":"2024-04-03","best_oa_location":null}},"created_at":"2025-09-20T08:26:16.165Z","updated_at":"2025-09-20T08:32:43.771Z","tags":[{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"modality","value":"Antibiotic","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"sample_size","value":"n=30","value_numeric":30},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"sex","value":"mixed","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"study_design","value":"Qualitative Study","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"warning","value":"Only abstract-level details are provided in the excerpt; full methods and generalizability cannot be assessed.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"warning","value":"Participant roles are listed, but counts by role are not provided in the excerpt.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2024.0203","tag_type":"warning","value":"This is a qualitative study; quantitative effect sizes are not applicable.","value_numeric":null}],"summaries":{"what_studied":"A qualitative study used an online survey and semistructured video interviews (March–August 2021) with stakeholders (dermatologists, infectious disease physicians, dermatology residents, and nonphysician clinicians) to identify barriers and facilitators to long-term oral antibiotic prescribing for acne, analyzed with the Theoretical Domains Framework.","key_result":"Among 30 participants (14 males, 16 females), guideline knowledge was high and antibiotic stewardship was viewed as a professional duty; five themes shaping long-term antibiotic use emerged: perceived lack of evidence to change dermatologic practice, patient demand and satisfaction pressures, discomfort discussing contraception, iPLEDGE-related barriers, and lack of systems to measure stewardship progress.","practice_takeaway":"Design outpatient dermatology antibiotic stewardship for acne to directly address clinician perceptions of evidence, patient expectations, contraception conversations, iPLEDGE hurdles, and to include mechanisms to track stewardship progress."}},{"doi":"10.1001/jamadermatol.2023.5355","pmid":"38170514","title":"Lived Experience of Acne and Acne Treatment in Transgender Patients","journal_title":"JAMA Dermatology","journal_issn":"2168-6068","published_at":"2024-01-04T00:00:00.000Z","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10765311","source_score":59,"is_retracted":false,"is_open_access":true,"raw_metadata":{"ooir":{"day":"2024-02-24","doi":"10.1001/jamadermatol.2023.5355","days":"30","issn":"2168-6068","rank":"5","field":"Clinical Medicine","score":"59","category":"Dermatology","categories":["Dermatology"],"_categories":["Dermatology"]},"pubmed":{"doi":"10.1001/jamadermatol.2023.5355","title":"Lived Experience of Acne and Acne Treatment in Transgender Patients.","journal":"JAMA dermatology","methods":"","results":"$3c","abstract":"$3d","keywords":[],"pubmed_id":"38170514","conclusions":"","publication_date":"2024-01-04T00:00:00"},"crossref":{"DOI":"10.1001/jamadermatol.2023.5355","URL":"https://doi.org/10.1001/jamadermatol.2023.5355","ISSN":["2168-6068"],"link":[{"URL":"https://jamanetwork.com/journals/jamadermatology/articlepdf/2813277/jamadermatology_gold_2024_oi_230063_1707346934.63785.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"page":"164","type":"journal-article","issue":"2","score":1,"title":["Lived Experience of Acne and Acne Treatment in Transgender Patients"],"author":[{"given":"Sarah","family":"Gold","sequence":"first","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Meron","family":"Siira","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Sigal","family":"Willner","sequence":"additional","affiliation":[{"name":"Department of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health, Atlanta, Georgia"}]},{"given":"Crescent","family":"Alcid","sequence":"additional","affiliation":[{"name":"Department of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health, Atlanta, Georgia"}]},{"given":"Suephy C.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Duke University School of Medicine and Durham VA Medical Center, Durham, North Carolina"}]},{"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia"}]},{"given":"Michael","family":"Goodman","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia"}]},{"given":"Cam","family":"Escoffery","sequence":"additional","affiliation":[{"name":"Department of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health, Atlanta, Georgia"}]},{"given":"Ashli","family":"Owen-Smith","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Behavioral Sciences, Georgia State University School of Public Health, Atlanta"}]},{"given":"Howa","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Clinical Resource Hub, Veterans Administration Veterans Integrated Service Network 7 Southeast Network, Decatur, Georgia"},{"name":"Associate Editor, JAMA Dermatology"}]}],"issued":{"date-parts":[[2024,2,1]]},"member":"10","prefix":"10.1001","source":"Crossref","volume":"160","created":{"date-time":"2024-01-03T16:02:20Z","timestamp":1704297740000,"date-parts":[[2024,1,3]]},"indexed":{"date-time":"2025-07-01T04:05:08Z","timestamp":1751342708713,"date-parts":[[2025,7,1]]},"subject":[],"abstract":"$3e","language":"en","relation":{},"resource":{"primary":{"URL":"https://jamanetwork.com/journals/jamadermatology/fullarticle/2813277"}},"subtitle":[],"deposited":{"date-time":"2024-02-21T16:02:07Z","timestamp":1708531327000,"date-parts":[[2024,2,21]]},"issn-type":[{"type":"print","value":"2168-6068"}],"published":{"date-parts":[[2024,2,1]]},"publisher":"American Medical Association (AMA)","reference":[{"DOI":"10.1016/j.jaad.2020.02.040","key":"doi230063r1","year":"2020","issue":"2","author":"Samuels","volume":"83","first-page":"532","unstructured":null,"article-title":"Acne vulgaris and risk of depression and anxiety: a meta-analytic review.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2021.2185","key":"doi230063r2","year":"2021","issue":"9","author":"Barbieri","volume":"157","first-page":"1040","unstructured":null,"article-title":"Patient perspectives on the lived experience of acne and its treatment among adult women with acne: a qualitative study.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/bjd.v183.2","key":"doi230063r3","year":"2020","issue":"2","author":"Ip","volume":"183","first-page":"349","unstructured":null,"article-title":"Young people’s perceptions of acne and acne treatments: secondary analysis of qualitative interview data.","journal-title":"Br J Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1111/jsm.12366","key":"doi230063r5","year":"2014","issue":"1","author":"Wierckx","volume":"11","first-page":"222","unstructured":null,"article-title":"Short- and long-term clinical skin effects of testosterone treatment in trans men.","journal-title":"J Sex Med","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2020.5347","key":"doi230063r6","year":"2021","issue":"3","author":"Thoreson","volume":"157","first-page":"290","unstructured":null,"article-title":"Incidence and factors associated with acne among transgender patients receiving masculinizing hormone therapy.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1089/trgh.2016.0023","key":"doi230063r7","year":"2016","issue":"1","author":"Owen-Smith","volume":"1","first-page":"187","unstructured":null,"article-title":"Perceptions of barriers to and facilitators of participation in health research among transgender people.","journal-title":"Transgend Health","doi-asserted-by":"publisher"},{"DOI":"10.1080/26895269.2022.2100644","key":"doi230063r8","year":"2022","issue":null,"author":"Coleman","volume":"23","first-page":"S1","unstructured":null,"article-title":"Standards of care for the health of transgender and gender diverse people.","journal-title":"Int J Transgender Health","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2019.09.008","key":"doi230063r9","year":"2023","issue":"1","author":"Perez-Chada","volume":"88","first-page":"86","unstructured":null,"article-title":"Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1177/120347540100500202","key":"doi230063r10","year":"2001","issue":"2","author":"Chren","volume":"5","first-page":"105","unstructured":null,"article-title":"Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases.","journal-title":"J Cutan Med Surg","doi-asserted-by":"publisher"},{"DOI":"10.1177/1203475418756379","key":"doi230063r11","year":"2018","issue":"3","author":"McLellan","volume":"22","first-page":"304","unstructured":null,"article-title":"Development of a comprehensive quality-of-life measure for facial and torso acne.","journal-title":"J Cutan Med Surg","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2022.2260","key":"doi230063r12","year":"2022","issue":"8","author":"Hopkins","volume":"158","first-page":"900","unstructured":null,"article-title":"Patient-reported outcome measures for health-related quality of life in patients with acne vulgaris: a systematic review of measure development and measurement properties.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1037/a0029597","key":"doi230063r14","year":"2012","issue":null,"author":"Hendricks","volume":"43","first-page":"460","unstructured":null,"article-title":"A conceptual framework for clinical work with transgender and gender nonconforming clients: an adaptation of the Minority Stress Model.","journal-title":"Prof Psychol Res Pr","doi-asserted-by":"publisher"},{"DOI":"10.1089/trgh.2016.0012","key":"doi230063r15","year":"2016","issue":"1","author":"Rood","volume":"1","first-page":"151","unstructured":null,"article-title":"Expecting rejection: understanding the minority stress experiences of transgender and gender-nonconforming individuals.","journal-title":"Transgend Health","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2015.0761","key":"doi230063r18","year":"2015","issue":"11","author":"Turrion-Merino","volume":"151","first-page":"1260","unstructured":null,"article-title":"Severe acne in female-to-male transgender patients.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2016.03.042","key":"doi230063r19","year":"2016","issue":"3","author":"Yeung","volume":"75","first-page":"648","unstructured":null,"article-title":"Prescribing isotretinoin in the United States for transgender individuals: ethical considerations.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1093/intqhc/mzm042","key":"doi230063r20","year":"2007","issue":"6","author":"Tong","volume":"19","first-page":"349","unstructured":null,"article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.","journal-title":"Int J Qual Health Care","doi-asserted-by":"publisher"},{"DOI":"10.1188/14.ONF.545-547","key":"doi230063r21","year":"2014","issue":"5","author":"Carter","volume":"41","first-page":"545","unstructured":null,"article-title":"The use of triangulation in qualitative research.","journal-title":"Oncol Nurs Forum","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi230063r22","year":"2006","issue":"8","author":"Magin","volume":"52","first-page":"978","unstructured":null,"article-title":"Psychological sequelae of acne vulgaris: results of a qualitative study.","journal-title":"Can Fam Physician","doi-asserted-by":null},{"DOI":"10.1007/s13555-018-0224-7","key":"doi230063r23","year":"2018","issue":"1","author":"Fabbrocini","volume":"8","first-page":"85","unstructured":null,"article-title":"A Qualitative investigation of the impact of acne on health-related quality of life (HRQL): development of a conceptual model.","journal-title":"Dermatol Ther (Heidelb)","doi-asserted-by":"publisher"},{"DOI":"10.1348/135910705X26128","key":"doi230063r24","year":"2005","issue":"Pt 2","author":"Murray","volume":"10","first-page":"183","unstructured":null,"article-title":"‘Nobody likes damaged goods’: the experience of adult visible acne.","journal-title":"Br J Health Psychol","doi-asserted-by":"publisher"},{"DOI":"10.1089/lgbt.2018.0265","key":"doi230063r25","year":"2020","issue":"1","author":"Bockting","volume":"7","first-page":"15","unstructured":null,"article-title":"The transgender identity survey: a measure of internalized transphobia.","journal-title":"LGBT Health","doi-asserted-by":"publisher"},{"DOI":"10.2340/actadv.v103.5123","key":"doi230063r26","year":"2023","issue":null,"author":"Ballanger","volume":"103","first-page":null,"unstructured":null,"article-title":"Truncal acne in adolescents and young adults: self-reported perception.","journal-title":"Acta Derm Venereol","doi-asserted-by":"publisher"},{"DOI":"10.2340/00015555-3834","key":"doi230063r27","year":"2021","issue":"7","author":"Dréno","volume":"101","first-page":null,"unstructured":null,"article-title":"Beyond the face: the hidden burden of truncal acne.","journal-title":"Acta Derm Venereol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.eprac.2023.02.002","key":"doi230063r28","year":"2023","issue":"5","author":"Chu","volume":"29","first-page":"353","unstructured":null,"article-title":"Incidence and factors associated with acne in transgender adolescents on testosterone: a retrospective cohort study.","journal-title":"Endocr Pract","doi-asserted-by":"publisher"},{"DOI":"10.11124/JBISRIR-2017-003869","key":"doi230063r29","year":"2019","issue":"9","author":"Rowniak","volume":"17","first-page":"1826","unstructured":null,"article-title":"Effect of cross-sex hormones on the quality of life, depression and anxiety of transgender individuals: a quantitative systematic review.","journal-title":"JBI Database System Rev Implement Rep","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2020.5353","key":"doi230063r30","year":"2021","issue":"3","author":"Braun","volume":"157","first-page":"344","unstructured":null,"article-title":"Moderate-to-severe acne and mental health symptoms in transmasculine persons who have received testosterone.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1007/s40257-021-00665-w","key":"doi230063r31","year":"2022","issue":"2","author":"Radi","volume":"23","first-page":"219","unstructured":null,"article-title":"Treating acne in transgender persons receiving testosterone: a practical guide.","journal-title":"Am J Clin Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jaad.2018.02.042","key":"doi230063r32","year":"2019","issue":"3","author":"Yeung","volume":"80","first-page":"581","unstructured":null,"article-title":"Dermatologic care for lesbian, gay, bisexual, and transgender persons: terminology, demographics, health disparities, and approaches to care.","journal-title":"J Am Acad Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.12788/cutis","key":"doi230063r33","year":"2022","issue":"3","author":"Nanda","volume":"109","first-page":"E18","unstructured":null,"article-title":"Removal of isotretinoin gender-based guidelines: inclusivity takes precedence.","journal-title":"Cutis","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.ajog.2019.07.043","key":"doi230063r36","year":"2020","issue":"2","author":"Krempasky","volume":"222","first-page":"134","unstructured":null,"article-title":"Contraception across the transmasculine spectrum.","journal-title":"Am J Obstet Gynecol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.contraception.2020.04.001","key":"doi230063r37","year":"2020","issue":"2","author":"Bonnington","volume":"102","first-page":"70","unstructured":null,"article-title":"Society of family planning clinical recommendations: contraceptive counseling for transgender and gender diverse people who were female sex assigned at birth.","journal-title":"Contraception","doi-asserted-by":"publisher"},{"DOI":"10.1001/jamadermatol.2019.1416","key":"doi230063r38","year":"2019","issue":"10","author":"Singer","volume":"155","first-page":"1162","unstructured":null,"article-title":"Psychiatric adverse events in patients taking isotretinoin as reported in a Food and Drug Administration database from 1997 to 2017.","journal-title":"JAMA Dermatol","doi-asserted-by":"publisher"},{"DOI":"10.1136/bmj.c5812","key":"doi230063r39","year":"2010","issue":null,"author":"Sundström","volume":"341","first-page":"c5812","unstructured":null,"article-title":"Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study.","journal-title":"BMJ","doi-asserted-by":"publisher"},{"DOI":"10.4088/JCP.10r05993","key":"doi230063r40","year":"2012","issue":"1","author":"Bremner","volume":"73","first-page":"37","unstructured":null,"article-title":"Retinoic acid and affective disorders: the evidence for an association.","journal-title":"J Clin Psychiatry","doi-asserted-by":"publisher"},{"DOI":"10.1136/bmjopen-2018-021549","key":"doi230063r41","year":"2019","issue":"1","author":"Li","volume":"9","first-page":null,"unstructured":null,"article-title":"Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis.","journal-title":"BMJ Open","doi-asserted-by":"publisher"},{"DOI":"10.1037/a0031774","key":"doi230063r42","year":"2013","issue":"3","author":"Budge","volume":"81","first-page":"545","unstructured":null,"article-title":"Anxiety and depression in transgender individuals: the roles of transition status, loss, social support, and coping.","journal-title":"J Consult Clin Psychol","doi-asserted-by":"publisher"},{"DOI":"10.1016/j.jadohealth.2015.04.027","key":"doi230063r43","year":"2015","issue":"4","author":"Olson","volume":"57","first-page":"374","unstructured":null,"article-title":"Baseline physiologic and psychosocial characteristics of transgender youth seeking care for gender dysphoria.","journal-title":"J Adolesc Health","doi-asserted-by":"publisher"},{"DOI":null,"key":"doi230063r13","year":"2011","issue":null,"author":"Graham","volume":null,"first-page":null,"unstructured":null,"article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi230063r4","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Jones? JM. LGBT identification in US ticks up to 7.1%. Published February 17, 2022. Accessed September 21, 2022. https://news.gallup.com/poll/389792/lgbt-identification-ticks-up.aspx","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi230063r16","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"iPLEDGE patient information/informed consent (for all patients). Accessed September 21, 2022. https://ipledgeprogram.com/#Main/Resources","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi230063r17","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"Isotretinoin iPLEDGE shared system REMS. Accessed September 21, 2022. https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=24","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi230063r34","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"US Food and Drug Administration. iPLEDGE risk evaluation and mitigation strategy (REMS). Accessed September 21, 2022. https://ipledgeprogram.com/#Main","article-title":null,"journal-title":null,"doi-asserted-by":null},{"DOI":null,"key":"doi230063r35","year":null,"issue":null,"author":null,"volume":null,"first-page":null,"unstructured":"iPLEDGE REMS guide for patients who can get pregnant. Accessed September 21, 2022. https://ipledgeprogram.com/#Main/Resources","article-title":null,"journal-title":null,"doi-asserted-by":null}],"short-title":[],"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2,1]]}},"content-domain":{"domain":[],"crossmark-restriction":false},"original-title":[],"container-title":["JAMA Dermatology"],"published-print":{"date-parts":[[2024,2,1]]},"reference-count":43,"published-online":null,"references-count":43,"short-container-title":["JAMA Dermatol"],"is-referenced-by-count":5},"unpaywall":{"doi":"10.1001/jamadermatol.2023.5355","is_oa":true,"title":"Lived Experience of Acne and Acne Treatment in Transgender Patients","updated":"2025-07-30T00:59:52+00:00","published_date":"2024-01-03","best_oa_location":{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10765311","pmh_id":"oai:pubmedcentral.nih.gov:10765311","url_for_pdf":null,"url_for_landing_page":"https://www.ncbi.nlm.nih.gov/pmc/articles/10765311"}}},"created_at":"2025-09-20T09:23:32.636Z","updated_at":"2025-09-20T09:31:36.884Z","tags":[{"paper_doi":"10.1001/jamadermatol.2023.5355","tag_type":"age_group","value":"adult","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.5355","tag_type":"category","value":"Dermatology","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.5355","tag_type":"condition","value":"Acne","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.5355","tag_type":"impact_flag","value":"limited_evidence","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.5355","tag_type":"sample_size","value":"n=32","value_numeric":32},{"paper_doi":"10.1001/jamadermatol.2023.5355","tag_type":"study_design","value":"Mixed-Methods Study","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.5355","tag_type":"warning","value":"Findings rely on self-reported acne severity and experiences; no clinical grading is provided in the abstract.","value_numeric":null},{"paper_doi":"10.1001/jamadermatol.2023.5355","tag_type":"warning","value":"Study design label is approximate: qualitative interviews with surveys in a mixed-methods framework.","value_numeric":null}],"summaries":{"limitations":"Small sample (n=32) from specific clinical settings; acne severity was self-rated rather than clinically graded; all participants were adults receiving gender-affirming hormone therapy.","what_studied":"Mixed-methods study of transgender and gender-diverse adults on gender-affirming hormone therapy, using semistructured interviews and surveys at a safety-net gender center and tertiary endocrinology/dermatology clinics (Jan 2021–Apr 2022) to examine lived experiences of acne and its treatment.","key_result":"Among 32 participants (mean age 32; 17 transgender men, 11 transgender women, 4 nonbinary), 10 (31%) rated their skin clear or almost clear, 11 (34%) reported mild acne, and 11 (34%) had moderate to severe acne. Themes included rejection/bullying, avoidance of social situations, depression/anxiety, worsened body appearance dissatisfaction, interference with feminine expression (transgender women), normalization as a sign of testosterone action (transgender men), common use of over-the-counter treatments, advice-seeking from clinicians/peers/online sources, and barriers such as cost, lack of multidisciplinary care, mistrust of the health system, and limited transgender-specific acne education.","practice_takeaway":"Screen for acne-related stigma and mental health effects in transgender and gender-diverse patients on gender-affirming hormones, and proactively address treatment barriers. Provide transgender-specific acne education, coordinate multidisciplinary care, and foster transgender-friendly clinical environments as recommended."}}],"initialOffset":8,"fetchConfig":{"kind":"tags","tags":[{"tag_type":"condition","value":"Acne"}]},"breadcrumbItems":[{"name":"Home","href":"/"},{"name":"Research Hub","href":"/hub"},{"name":"Conditions","href":"/hub/tag/condition"},{"name":"Acne"}],"hrefConfig":{"basePath":"/hub/papers","webViewQueryParams":{"hub_ctx":"tag","hub_tag_type":"condition","hub_tag_value":"Acne"}}}]]

Papers